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ABSTRACT 
Background:  Compliance with CPAP treatment for OSA is not reliably predicted by 
the severity of symptoms or physiological variables. I conducted a series of studies to 
examine a range of factors that may affect compliance with CPAP. 
 
Methods:  I performed a retrospective study examining association of demographic 
factors and OSA severity with long-term CPAP compliance. In a prospective study, I 
looked at the correlation of short and long-term CPAP compliance with socio-
economic status, education, type D personality, demographics, disease severity, 
mood and clinician’s prediction. I undertook a prospective, cross-over trial comparing 
the impact of Bi-level PAP therapy in individuals with low tolerance of CPAP. 
 
Results:  In a retrospective analysis, an improvement in subjective daytime 
somnolence was correlated with optimal compliance.  In the prospective study, 
median compliance with CPAP at 6 months was 5.6 (3.4- 7.1) hours / night with 73% 
of subjects using CPAP ≥4 hours/night. Compliance with CPAP was not found to be 
associated with socio-economic class for people in work, type D personality, 
education, sex, age, baseline sleepiness (ESS score) or disease severity (ODI). The 
clinician’s initial impression had no predictive value for individual patients. Subjects 
who were long-term unemployed or reporting mood disorders (High Beck’s 
Depression Index scores) were likely to have poor compliance and sub-optimal CPAP 
usage (OR 4.6, p = 0.011 and OR 1.4. p=0.04 respectively).  Subjects experiencing side 
effects after the first night on treatment showed lower acceptance and subsequent 
compliance. In the cross-over trial, changing to Bi-level PAP in individuals with 
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suboptimal compliance due to pressure related intolerance, did not lead to an 
improvement in CPAP compliance. In post-hoc analysis, compliance and comfort were 
better in the subgroup that complained of difficulty with exhalation on CPAP.   
 
Conclusion:  My research as presented in this thesis, did not find an association 
between disease severity (ODI), socio-economic status (for people in employment), 
education or personality type and CPAP compliance. My research demonstrated that 
subjects with long-term unemployment, mood disorders and those experiencing side 
effects on the first night of treatment were likely to have sub-optimal compliance. 
Changing to Bi-level PAP is only likely to be useful for a sub-group of subjects 
experiencing pressure related intolerance. More research is needed to explore 
whether intensive support to individuals with OSA and long term unemployment, as 
well as mood disorders, may improve compliance.   
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CHAPTER I   INTRODUCTION 
In this chapter, I have presented a summary of the evidence related to compliance 
with Continuous positive airway pressure (CPAP) therapy in Obstructive sleep apnoea 
(OSA). Section 1.1 is an overview of the prevalence and impact of OSA. Section 1.2 
describes the principles of CPAP therapy, its indications, effectiveness and optimal 
use. Section 1.3 reviews the factors determining the acceptance and compliance with 
CPAP.  
 
SECTION 1.1   OBSTRUCTIVE SLEEP APNOEA 
 
1.1.1    Definitions, prevalence and diagnosis  
OSA is a condition characterised by repeated episodes of partial or complete collapse 
of the upper airway during sleep. The airway collapse is associated with reduced or 
absent airflow despite on-going efforts against the occluded airway. An obstructive 
apnoea is defined as a ≥10 second pause in airflow with on-going ventilatory effort. 
Obstructive hypopnoea is defined as reduction, but not complete cessation of airflow 
associated fall in arterial oxygen saturation. The American Academy of Sleep Medicine 
task force proposed that an obstructive hypopnoea is either  
(i) A ≥ 30% drop in the nasal flow signal combined with ≥ 4% drop in the 
oxygen saturation or 
(ii) A ≥ 50% drop in the nasal flow signal for ≥ 10 seconds with ≥ 3% drop in 
the oxygen saturation (Berry RB, 2007). This definition was modified in 
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2012 as a ≥ 30% drop in nasal flow signal for ≥ 10 seconds associated with 
≥3% drop in oxygen saturation or arousal (AASM 2012). The 10-second 
criterion used to diagnose these events is used by convention (Berry RB, 
2007; Quan SF, 1999). The apnoea-hypopnoea index (AHI) is the number 
of events per hour as recorded during sleep. 
In 1837, Charles Dickens gave what may be the first published description of OSA in 
“Pickwick papers” (Dickens C, 1837) “Joe”, one of the characters was described as, “… 
and on the box sat a fat and red-faced boy, in a state of somnolency.” Sir William 
Osler, in 1918 wrote of "A remarkable phenomenon associated with excessive fat in 
young people, is an uncontrollable tendency to sleep-like the fat boy in Pickwick" 
(Osler, 1918).  In 1956, Burwell et al reported several obese, hyper somnolent patients 
with respiratory and cardiac failure and coined the term “Pickwickian Syndrome” 
(Burwell CS, 1956).  
It wasn’t until 1965, that a group of French investigators made the important 
observation that “Pickwickian” patients had repetitive apnoeic events during sleep 
(Gastaut H, 1966). A group of German investigators subsequently described a marked 
improvement in patients treated with tracheostomy (Kuhlo W, 1969). They suggested 
that a likely reason why apnoeas occur is the collapse and closure of the upper airway 
during sleep.  
The patency and the tendency of the airway to collapse during sleep is affected by a 
number of factors. These include the size and shape of the upper airway, the 
strength and timing of reflex activation of upper airway dilator muscles, surface 
16 
 
forces and the load applied to the airway which is affected by mass loading (usually 
by adiposity) and position (supine or side lying). Imbalances between the mechanical 
load and compensatory neuromuscular responses during sleep can result in collapse 
of the airway (Figure1) (Patil S, 2007). 
Figure 1: Anatomy of airway in normal individuals and in OSA  
 
                            Normal airway 
  
 
                    Obstructed airway in OSA  
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Apnoeas and hypopneas are usually terminated by arousal from sleep. This may lead 
to interrupted and unrefreshing sleep and excessive daytime sleepiness.  Obstructive 
sleep apnoea hypopnoea syndrome also known as OSAHS, is thus a symptom 
complex of excessive daytime sleepiness in patients with significant obstructive 
apnoeas and hypopneas during sleep. 
To diagnose OSAHS, individuals must fulfil criteria 1 or 2, plus criterion 3 (Quan SF, 
1999). 
1. Excessive daytime sleepiness that is not better explained by other factors. 
2. Two or more of the following that are not better explained by other factors: 
 Choking or gasping during sleep, 
 Recurrent awakenings from sleep, 
 Unrefreshing sleep, 
 Daytime fatigue, 
 Impaired concentration and/or 
3. Overnight monitoring demonstrates five or more obstructed breathing    
events per hour during sleep. These events may include any combination of  
obstructive apnoeas/ hypopneas or respiratory effort related arousals (RERA). 
RERA is defined as a sequence of breaths characterized by increasing respiratory effort 
leading to an arousal from sleep, but which does not meet criteria for an apnoea or 
hypopnoea. These events must fulfil both of the following criteria: 
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1. Pattern of progressively more negative oesophageal pressure, terminated   
by a sudden change in pressure to a less negative level and an arousal 
2.   The event lasts 10 seconds or longer 
The justification for using > 5 obstructive events (apnoeas or hypopneas) per hour in 
diagnosing OSA is based on epidemiological evidence that suggests that clinically 
significant adverse health effects related to OSA (including sleepiness, hypertension 
and motor vehicle accidents), may be observed at this threshold (Young T 1997a; 
Young T 1997b; Young T 1996). Based on the frequency of obstructive breathing 
events as measured by AHI, OSA severity has been divided into 3 categories (Quan 
SF 1999): 
       Mild               5-14 events per hour 
       Moderate     15-30 events per hour 
       Severe           > 30 events per hour 
However, there is poor correlation between these criteria and the severity of   
symptoms in individuals with OSA (Yue H, 2009; Johansson P, 2009). 
 
Prevalence 
Epidemiological studies have estimated that around 3-7% of adult men and 2-5% of 
adult women have OSAHS (Lindberg E 2000; Punjabi NM 2008). However, the 
prevalence of mild OSA (AHI>5 hr-1) vary from 3 to 28% and moderate OSA range from 
1 to 14% in middle aged subjects (Bixler EO 1998; Bixler EO 2001; Young T 1993) (Table 
1). This variability in reported prevalence is often a function of sample sizes and 
variance in definition of OSA. In studies with laboratory confirmation of OSA, the 
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prevalence estimates were in closer agreement (Young T, 1993; Bixler EO, 1998; Duran 
J, 2001). 
Table 1:  Prevalence of obstructive sleep apnoea in different population 
groups 
 
Study  
Location 
N Age 
Range  
(years) 
Estimated  
Prevalence of  
AHI 5  
events/hour  
(% [95% CI]) 
 
Estimated  
Prevalence of  
AHI 15  
events/hour  
(% [95% CI]) 
 
   Men Women Men Women 
Wisconsin  626 30–60 24 (19–28) 9 (6–12) 9 (6–11) 4 (2–7) 
India 250 35-65 19.5% Na 8.4% Na 
Korea 309 40-69 27 16 10.1 4.7 
Pennsylvania 1,741 20–99 17 (15–20) Not given 7 (6–9) 2 (2–3) 
Spain 400 30–70 26 (20–32) 28 (20–35) 14 (10–18) 7 (3–11) 
 
(Bearpark H, 1995; Duran J, 2001; Ip MS, 2001; Kim J, 2004; Udwadia ZF, 2004; 
Peppard PE, 2000). 
1.1.2 Risk factors 
 
Age:  The prevalence of OSA increases with age. In the elderly, the prevalence of 
moderate OSA varies from 7- 44% (Duran J, 2001; Bixler EO, 1998, Bixler EO, 2001, 
Ancoli-Israel S, 1991). Data from “Sleep Heart Health Study” (Sahar E, 2001) and other 
observational studies have shown that the prevalence of OSA increases steadily 
during the middle age and plateaus around 65 years.  
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Excess body weight:  Body weight has been shown to be a strong independent 
predictor for OSA (Bixler EO, 1998; Bearpark H, 1995; Duran J, 2001; Ip MS, 2001; Ip 
MS, 2004).  In the Wisconsin Sleep Cohort study, one standard deviation increase in 
the body weight was associated with a fourfold increase in disease prevalence (Young 
T, 1993).  
Fat distribution- Central obesity, which has close association with neck 
circumference, is associated with the severity of OSA, particularly in men (Davidson 
TM, 2008; Martinez Rivera C, 2008).  Postulated links between the two factors include 
(i) tracheal tug and hence diminished upper airway calibre as a result of central 
obesity and (ii) leptin deficiency in obese individuals and hence fluid shift with 
resultant reduced upper airway calibre. (Polotsky M, 2012; White WH, 2013; Degache 
F, 2013). 
Sex: It is recognised that men are at higher risk of developing OSA than women. Clinic 
based studies show a significant gender gap in OSA prevalence with a ratio of men 
versus women of 5 to 8:1 (Strohl KP, 1996; Young T, 1993; Bixler EO, 2001; Duran J, 
2001; Redline S, 1994).  In the general population, this gender difference is less 
marked. Men outnumber women at 2 to 3: 1 with a further narrowing of gender gap 
after menopause (Bixler EO, 2001). 
Race:  Asians have a higher severity than white Caucasians perhaps due to specific 
cephalometric differences between the two populations (Ong KC, 1998; Li KK, 2000; 
Lam B, 2005). African – Americans however, have similar disease prevalence as white 
Caucasians Americans (Young T, 2002; Redline S, 1997). 
Smoking and Alcohol: Current smoking is linked with a higher prevalence of snoring 
and OSA (Stradling JR, 1991; Jennum P, 1992; Wetter DW, 1994). This may be due to 
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altered neural and mechanical properties of the upper airway secondary to 
inflammation from smoking resulting in increased airway collapse.  
Consumption of alcohol in moderate-severe quantities is also known to influence the 
severity of OSA (Scanlan MJ, 2000). Possible explanations proposed for its effect on 
OSA include reduction in arousal response, selective reduction in motor activity of 
genioglossus and hypoglossus (Krol RC, 1984), increased nasal mucosa oedema and 
increased resistance (Robinson RW, 1985; Issa FG, 1982). 
Familial and genetic: First-degree relatives have a higher risk of the disease (Redline 
S, 2000; Redline S, 1995). Segregation analysis of the Cleveland Family study showed 
that up to 35% of the variance in disease severity may be attributable to genetic 
factors (Buxbaum SG, 2002) and distribution of fat may be a contributory factor in this 
association. 
Craniofacial anatomy: Cephalometric analyses has shown that retrognathia, enlarged   
tongue/soft palate, inferiorly positioned hyoid bone, retro position of mandible and 
maxilla, tonsillar hypertrophy, brachycephaly, shorter cranial base and an acute 
cranial flexure may predispose to apnoea and hypopnoea during sleep (Li KK, 2000; 
Cistulli PA, 1996). Polycystic ovary syndrome, hypothyroidism, acromegaly and 
pregnancy may be associated with OSA, due to narrowing of upper airway by 
increased soft tissue and/ or by macroglossia (Vgontzas AN, 2001; Fogel RB, 2001; 
Rajgopal KR, 1984; Pien GW, 2005) It should be noted that in each of these conditions 
there are also endocrine changes, which may affect tone of the muscles in the upper 
airway.  
 
22 
 
1.1.3    Clinical presentation 
Individuals with OSA commonly present with a history of loud snoring, witnessed 
apnoeas, interrupted or unrefreshing sleep and excessive daytime sleepiness. They 
usually have 2 or more of the following symptoms/signs at the time of presentation.   
1.1.3.1   Nocturnal symptoms and signs 
 Snoring is the most common symptom of OSA, present in 70-95% of patients (Whyte 
KF, 1989). Habitual snorers (snore 3-7 times per week) are more likely to have OSA of 
mild-moderate severity compared to non-habitual snorers (OR 2.87) (Young T, 1993; 
Sharma SK, 2006). Snoring is however very common in the general population and 
therefore not specific to the diagnosis of OSA. Snoring is also significantly associated 
with male sex, age 25 or more, obesity, daytime sleepiness or naps, night time 
awakenings, consuming large amounts of caffeine and smoking (Ohayon MM 1993). 
 Witnessed apnoeas It is usually the bed partner who gives the history of apnoeic 
episodes (Hoffstein V, 1993) as, most patients are unaware of apnoeas.  Witnessed 
apnoeas are a good predictor of OSA (Deegan PC, 1996; Hoffstein V, 1993) although 
not specific and can also occur, in association with central sleep apnoea or Cheyne- 
stokes respiration.  
Choking or dyspnoea Choking or dyspnoea that interrupts sleep is reported by 18% 
to 31% of patients with OSA (Kales A, 1985; Maislin G, 1995). Vigorous inspiratory 
effort to overcome upper airway obstruction can lead to an enhanced negative intra-
thoracic pressure swings, increasing venous return, pulmonary capillary wedge 
pressure and can contribute to the sensation of dyspnoea (Buda AJ, 1981). 
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Interrupted or unrefreshing sleep Upper airway collapse is usually terminated by 
arousal. Arousals are defined as a shift from a state of sleep to a state of wakefulness 
(Phillipson EA, 1978) and are due to increased respiratory effort against the upper 
airway obstruction (Berry RB, 1997, Gold AR, 1986). Repeated episodes of apnoeas 
followed by arousals leads to significantly interrupted and hence unrefreshing sleep. 
 Nocturia Nocturia is reported by up to 50% of patients with OSA (Guilleminault C, 
2004; Barker JC, 1988; Stewart RB, 1992; Middelkoop HA, 1996) and may correlate 
with severity of disease (Oztura I, 2006; Kiely JL, 2000; Fitzgerald MP, 2006). Proposed 
mechanisms include increased abdominal pressure and increased atrial natriuretic 
peptide (Kreiger J, 1989; Umlaut M, 2004). 
 Erectile dysfunction Erectile dysfunction with impaired nocturnal and early morning 
penile tumescence (Margel D, 2006; Gonsalves MA, 2005) and a loss of interest in sex 
is common in men with OSA (Watson R, Sleep Res, 1987). Proposed mechanisms 
include vascular, endocrine and autonomic neural pathways. (FanfullaF, 2000). There 
is an association between erectile dysfunction and nocturnal arterial oxygen 
desaturation (Gonsalves MA, 2005) and endothelial dysfunction (Karacan I 1995; 
Santamaria JD, 1988; Grunstein RR, 1994). 
 
 
1.1.3.2   Daytime symptoms 
Excessive daytime sleepiness This is the most common complaint of patients with 
OSA (Kales A 1985; Hofstein V 1993). Attempts to assess subjective sleepiness have 
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been made using self-reported sleepiness scales (e.g. Epworth sleepiness scale, Berlin 
questionnaire, Stanford sleepiness scale) (Johns MW, 1991; Herscovitch J, 1981) and 
by measuring mean sleep latencies or surrogates for sleep in a sleep laboratory. 
The Epworth sleepiness scale score (ESS) (Appendix 1) is a widely used self-reported 
scale to assess daytime sleep propensity (Johns MW, 1991). The ESS asks people to 
rate on a 4-point scale their chance of falling asleep in 8 different situations or 
activities (0- no chance of falling asleep, 1 is slight chance, 2 is moderate chance and 
3 is severe chance). A score of greater than 10 out of a maximum of 24 is considered 
abnormal and suggests excessive daytime sleepiness (Johns MW, 1991, Johns MW, 
1997). It may underestimate the severity of sleepiness in the setting of chronic hyper 
somnolence and may overestimate the sleepiness in depression or chronic fatigue 
syndrome (Chervin RD, 1999). Whilst this is still a subjective way of assessing daytime 
sleepiness and is not a perfect tool, it remains the most widely studied and validated 
tool for assessing daytime sleepiness. However, only 23% of women and 16% of men 
with OSA (AHI of 5 or more) reported symptoms of sleepiness, defined by ESS>10. 
There are however individual differences and lack of correlation between AHI and 
measures of daytime sleepiness (Gottlieb DJ, 1999, Chervin RD, 1999). 
Other daytime symptoms Other symptoms, which are not specific but are commonly 
associated with OSA, are memory impairment, fatigue, lack of concentration and 
changes in behaviour/ personality, depression. Untreated OSA is also proven to be 
associated with matrimonial disharmony (Reishtein JL, 2006). 
Road traffic accidents- Individuals with OSA are at increased risk for road traffic 
accidents (Shiomi T, 2002; George CF, 2001, Horstmann S, 2000, Teran Santos J, 1999, 
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Young T, 1997a; Tragear V, 2009). The prevalence of OSA is higher amongst 
commercial drivers with estimates of mild OSA of around 28% and severe OSA around 
5% (Pack AI, 2006; Tregear V, 2009).  
1.1.4  Diagnosis 
The overnight polysomnogram (PSG) has been proposed as the gold standard test for 
diagnosing OSA. It is a detailed analysis of respiratory events combined with 
information about the stages of sleep and arousals based on electroencephalogram 
criteria (Cheeson AL, 1997). PSGs are resource intensive and usually require facilities 
for overnight stay in a sleep laboratory and trained sleep scientists to analyse the 
studies. Despite consensus guidelines and attempts at a global standardisation in 
reporting PSGs, inconsistencies exist in the analysis and interpretation in different 
sleep laboratories (Redline S, 2000; AASAM, 2007). Moreover, AHI measured by PSG 
as a marker of OSA lacks a close correlation with excessive daytime somnolence, and 
with morbidity or mortality (Bennett JA, 1999). There is poor repeatability in the same 
laboratory and instrumentation may affect the quality of sleep and sleeping  
position and hence the AHI.  
Portable, home based, diagnostic studies including limited (respiratory) sleep studies 
and nocturnal arterial pulse oximetry monitoring are an alternative to PSG. Limited 
sleep studies monitor oro-nasal flow, thoracic and abdominal movements, arterial 
oxygen saturation, snoring, heart rate and body position, whereas nocturnal oximetry 
records oxygen saturation and heart rate via non-invasive arterial pulse oximeters. 
Limited sleep studies have clinical correlation with and cost savings compared to PSG 
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(Golpe R, 2002, Whittle AT, 1997; Verse T, 2000). The primary weakness is the lack of 
sleep staging, which leads to an uncertainty as to whether respiratory events were 
occurring during sleep or wakefulness.  
 An alternative diagnostic strategy in suspected sleep apnoea patients, is to use 
nocturnal oximetry and if it is inconclusive, then to proceed to respiratory sleep study 
or PSG. In nocturnal oximetry, a repetitive pattern of 4% or more desaturations 
followed by a quick return to baseline is typical of OSA. Hypopneas can be present 
with 3% desaturation and hence are not necessarily picked up on oximetry criteria 
alone (AASM, 2007, AASM 2012). If the oximetry is non-diagnostic, further 
investigations including respiratory sleep studies or PSG may be done to confirm the 
diagnosis. Though nocturnal oximetry is useful in the screening of moderate to severe 
disease, it is not helpful in mild OSA as it does not distinguish respiratory effort related 
arousals (RERA) or hypopneas associated with 3% desaturation, which are common in 
mild disease (Cooper BG, 1991). The sensitivity of nocturnal oximetry in diagnosing 
OSA is variable from 31-98% with specificity 41-98% (Netzer N 2001) due to 
differences in equipment with variable signal averaging time and threshold values of 
desaturation index used in different studies (Table 2). 
In clinical practice, the diagnostic sensitivity and specificity are likely to improve 
further if the symptoms of OSA are taken into consideration.  Sleep studies including 
4% oxygen desaturation index threshold of >10 per hour in symptomatic individuals 
can reliably be used to diagnose OSA. In a randomised controlled trial involving 246 
patients, PSG derived AHI and oximetry derived respiratory disturbance index (RDI 
calculated as a total number of 4% drop in oxygen saturations from baseline divided 
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by total monitor probe on time) were highly correlated (R=0.97). The mean difference 
between AHI and RDI was 2.7. Using a criterion of 10 events every hour for AHI and 
Respiratory disturbance index (RDI), the sensitivity and specificity were 97% and 80% 
respectively (Vazquez JC, 2000). 
Table 2:  Sensitivity and specificity of nocturnal oximetry in diagnosing OSA. 
 
Author 
 
Study 
Population, 
No 
AHI/ODI Cut-
off Point 
 
Screening 
Specificity, % 
 
Screening 
Sensitivity, % 
 
Ryan S (1995)  69 ≥ 15 100 31 
Levy P (1996)  301 ≥ 15 94 77 
Lacassagne I (1997)  329 ≥ 15 57.8 89 
Sano K (1998)  40 ≥ 15 83.3 73.5 
Olson LG (1999)  113 ≥ 15 70 88 
Golpe R (1999)  116 ≥ 10 97 84 
Brouillete RT (2000)  349 NA 96 58 
Nuber R (2000)  70 NA 77.8 85.2–91.8 
Vazquez JC (2000)  246 ≥ 10 80 97 
 
1.1.5   CPAP therapy 
 
1.1.5.1 Principles of CPAP therapy – Initially described in 1981 (Sullivan CE, 
1981). CPAP IS the primary modality of treatment for OSA. With a mask covering the 
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nose or nose and mouth with a tight seal attached via a hose to a pressure generator, 
it works as a pneumatic splint to prevent upper airway collapse during  
sleep (Figure2).  
Figure 2: CPAP with the pneumatic splint 
 
1.1.5.2   Mechanism of upper airway occlusion and its prevention by 
nasal CPAP 
When the patient is awake, muscle tone prevents collapse of the upper airway during 
inspiration. During sleep, the tongue and soft palate are sucked against the posterior 
oropharyngeal wall leading to airway narrowing and closure. CPAP provides a 
pneumatic splint and keeps the upper airway open (Sullivan CE 1981).  
Though mechanical pneumatic splinting is thought to be the primary physiological 
process by which CPAP functions, there are other postulated mechanisms.  One 
proposal is that upper airway stabilization is achieved by an increase in lung volume, 
which increases the tone of upper airway dilator muscle and prevents collapse (Berry 
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RB 2003; Hoffstein V 1984). Another is that forces associated with increased lung 
volume are transmitted to upper airway by the trachea resulting in a “tracheal tug” 
which stabilizes the airway (Begle RL, 1990; Brown IG, 1985). 
1.1.5.3   Effectiveness of CPAP therapy 
 CPAP is effective in reducing and treating OSA (Ballester E, 1999; Gay P, 2006). There 
is evidence that CPAP treatment improves daytime sleepiness. In a meta- analysis 
including 745 patients, treatment with CPAP was associated with an improvement in 
ESS scores (4.75 vs. 1.10, p<0.001) in severe OSA patients with sleepiness.  Control 
treatment comprised of either no or minimal therapy (lifestyle changes/ weight 
intervention) OR a true placebo such as Sham CPAP (Patel SR, 2003). Objective 
measures of sleepiness were also shown to improve (Patel SR, 2003). 
Treatment with CPAP has been shown to improve quality of life. Both general (Short 
Form 36) and disease specific quality of life indices (Sleep apnoea quality of life index, 
functional outcome of sleep questionnaire) (Smith IE, 1995; D’ambrosia C, 1999; 
Engleman HM, 1996; Kotterba S, 1998; Redline S, 1998) show an improvement on 
CPAP treatment in symptomatic individuals.  
Improvement in driving simulation performance is seen as early as a few days after 
starting treatment and (Orth M, 2005; Turkington PM, 2004) some of the 
improvements appears to be sustained up to 1 week after the withdrawal of CPAP 
(Kribbs NB, 1993a; Tregear S, 2007; Kohler M, 2011). 
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A study which compared an OSA cohort using CPAP with population based controls, 
found the incidence of road traffic accidents is reduced significantly in the group who 
were treated with CPAP (Karimi M, 2015).  
1.1.5.4   Impact of CPAP therapy on cardiovascular risk factors 
Extensive research has evaluated the relationship between OSA and hypertension and 
the impact of CPAP. (Nieto FJ, 2000; Hla KM, 1994; Carlson JT, 1994; Bartel PR, 1995; 
Young T, 1997b; O’Connor GT, 2009). CPAP treatment leads to a reduction in blood 
pressure (Dimsdale JE, 2000; Faccenda JF, 2001; Pepperrell JC, 2002; Becker HF, 2003; 
Norman D, 2006) but the results have not been consistent, in non-sleepy individuals 
(Robinson GV, 2006; Choi JB 2006, Barbe F, 2001, Monteserrat JM, 2007, Campos-
Rodriguez F, 2006). CPAP therapy reduced the risks of future cardiac events including 
myocardial infarction and atrial tachyarrhythmia (Buchner N J, 2007; Neilan T G, 2013) 
as well as the risk of future stroke.       
In different observational studies, CPAP therapy is associated with reduced mortality, 
though no randomised controlled studies have been done to prove this association 
(Campos-Rodriguez F, 2012; Campos-Rodriguez F, 2005; Marti S, 2002).   
1.1.5.5   Impact of CPAP therapy on neurocognition and performance 
    Objectively measured cognitive performances assessed by a battery of 
neuropsychological tests were impaired in individuals with OSA. (Engleman HM, 2000; 
Redline S, 1997; Kim HC, 1997; Bedard MA, 1991; Naegele B, 1995; Greenberg GD, 
1987).  Evidence suggests that this impairment maybe reversible with CPAP 
(Engleman HM, 1994a). 
31 
 
1.1.5.6   CPAP Prescription 
According to the National institute of clinical excellence (NICE) technological appraisal 
(NICE 2008), CPAP is recommended as a treatment for adults with moderate or severe 
symptomatic sleep apnoea.  
In individuals with mild OSA, CPAP is recommended if: 
Symptoms affect their quality of life and ability to go about their daily activities, and 
lifestyle advice (for example about losing weight, stopping smoking and cutting down 
on alcohol) and all other possible treatments have not worked or are not appropriate. 
In summary, CPAP treatment is known to be an effective treatment in improving 
daytime sleepiness and quality of life (both generic and sleep apnoea specific) in 
individuals with OSA. CPAP is also shown to reduce the risk of road traffic accidents, 
blood pressure and other cardiovascular or cerebrovascular complications. 
 
 
 
 
1.2   CPAP ACCEPTANCE & COMPLIANCE 
 
Though CPAP is an effective treatment in reversing sleep apnoea (McArdle N, 2001) 
not everyone who is prescribed the treatment, “accepts” it. Also among those who 
initially accept the treatment, subsequent use may vary from a few nights to all nights 
every week and from few hours per night to most of the night. 
1.2.1  CPAP acceptance  
CPAP acceptance is defined as the willingness to consider CPAP treatment and to use 
it for at least a period of time. There is no consensus on the specific period of time, to 
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define whether the treatment is accepted or not. It can vary from accepting the idea 
of having CPAP trial for one week (McArdle N, 1999; Kreiger J, 1996) to a more 
pronged period (Rolfe I, 1991).  
If initial acceptance is defined as individuals willing to undergo CPAP titration and use 
it for at least one week, 5-50% of individuals appear to reject treatment (McArdle N, 
1999; Kreiger J, 1996; Rauscher H, 1991; Fleury B, 1994; Engleman HM, 2003).  In one 
of the early studies, out of 233 patients who were recommended CPAP treatment, 19 
(8%) refused treatment and amongst the initial acceptors 181 (78%) were still using 
the treatment during the follow up period of almost 3 years (Kreiger J, 1992). In a large 
observational study, 5% of patients with OSA booked for CPAP treatment did not turn 
up repeatedly. Compared to the individuals who accepted CPAP treatment for the trial 
14% of men declined to accept the treatment compared to 31% of women (Engleman 
HM, 1999).  
Sleepiness and severity of disease have not been consistently associated with 
acceptance. In a prospective observational study, no association was found between 
poor initial acceptance and daytime sleepiness (measured by ESS) or AHI. Others have 
shown poor acceptance amongst individuals who are not sleepy or where the severity 
of sleep apnoea was less profound (Barbe F, 2001, Rauscher H, 1991).  
Another study, in a health system where the cost of the treatment (partial or full) is 
incurred by the patient, showed that out of 162 consecutive patients with OSA of 
variable severity, only 40% who were recommended treatment accepted it. This was 
despite the fact that that patients had to pay only 30% of the cost towards CPAP. 
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Factors associated with the acceptance included older age, higher income, no bed 
partner and more severe OSA. These were also the patients who would have heard 
positive experiences from family and friends (Simon-Tuval T, 2009).  
Long-term CPAP Compliance 
In a study of long-term CPAP use in OSA, independent predictors of long-term CPAP 
adherence were disease severity (AHI ≥15/ hour), daytime somnolence (ESS>10), 
history of snoring (McArdle N, 1999; Chai-Coetzer CL, 2013). Initial CPAP adherence 
(one month) was associated with higher CPAP adherence at 12 months.  
Amongst patients who accept treatment, 12-25% may be expected to discontinue this 
in a 3-year follow up (McArdle N, 1999; Kreiger J, 1996; Popescu G, 2001).   
In a study where 209 patients were offered a loan of CPAP machine for a home trial 
and were followed up in the clinic with further usage data available at 1 year follow 
up (Popescu G, 2000). Following the initial treatment trial 196 (94%) tried a 
treatment trial at home and 153 (73%) continued. Factors associated with continued 
use of CPAP at 1 year were disease severity and a greater change in daytime 
somnolence following initial therapy, while the lack of titration and failure to 
improve symptoms are likely to lead to poor compliance (Wang Y, 2012). 
Compliance is defined as the “degree to which a patient correctly follows medical                     
advice”. Most commonly, it refers to medication or drug compliance, but it can also 
apply to other situations such as medical device use, self-care, self-directed 
exercises, or therapy sessions. Compliance with CPAP treatment can be defined as 
the average use of CPAP every night. Compliance is monitored by inbuilt clock 
counters (measures the number of hours CPAP is used) or by electronic cards, which 
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record more accurately the number of hours that the mask was on the face and 
pressure delivered and thus gives information about night to night variability. There 
is no accepted definition of “optimal CPAP compliance” though the expert 
consensus view is to use it more than 4 hours per night and its use more than 70% of 
the nights (Kribbs NBb, 93). This specific figure of 4 hours per night is arbitrary and is 
based on minimal criteria for adequate sleep from general sleep duration. It is 
however accepted that CPAP should be used throughout the duration of the sleep to 
get the best benefits. 
There is a linear dose response relationship between the number of hours CPAP is 
used and measures of subjective (ESS) and objective sleepiness (Multiple sleep latency 
testing- MSLT) (Weaver T, 2007).  When assessing the impact of CPAP on quality of 
life (i.e. FOSQ), benefit is seen when used up to 7 hours with no further benefit beyond 
that period (Weaver T, 2007).  
Compliance with CPAP treatment is quite similar to observed adherence rates to other 
treatment for chronic illnesses.  Amongst asthmatics, adherence to medications 
measured as percentage of prescribed medication taken ranges from 30% to 70% 
(Bender BG, GINA, Rand CS; Reid D, 2000; Pearson MH, 1999). A similar pattern of 
adherence has been observed in other chronic illnesses including hypertension, 
depression, rheumatological illnesses and diabetes and poor adherence to medication 
is also known to influence the health related outcomes in chronic illnesses (Costa FV, 
1996; WHO 2003). 
Factors that are known to influence or likely to affect the initial acceptance and 
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subsequent compliance with the treatment are discussed in the sections 1.2.1- 1.2.5 
 
1.2.2    Sleep apnoea related factors (Severity of OSA) 
  
The severity of underlying OSA (higher AHI, sleepiness and snoring) has been 
proposed as an important factor, which affects subsequent compliance with CPAP 
therapy in symptomatic individuals. The relationship is however not very clear with 
conflicting results from different studies (Lloberes P, 2004; Krieger J, 1992; McArdle 
N, 1999; Rauscher H, 1993; Somners ML, 2011). However, in a study involving 47 
patients with OSA who were followed up closely at 2-8 weeks’ intervals, AHI was not 
found to be associated with optimal compliance (Reeves-Hoche MK, 1994; Engleman 
HM, 1999; Engleman HM, 1994b). In a randomised multicentre trial in Europe 
involving 121 patients with OSA who had covert CPAP monitoring, compliance at 3 
months was not found to be associated with baseline AHI or severity of OSA. (Pepin 
JL, 1999) 
The level of nocturnal hypoxemia (minimum oxygen desaturation and 4% oxygen 
desaturation index), another parameter related to the severity of OSA, has not been 
consistently shown to be associated with adherence and compliance with CPAP 
(Kribbs NB, 2007; Noseda A, 2000). 
Amongst the factors associated with the severity of OSA a consistent association 
between adherence and compliance with CPAP has been found with pre-treatment 
ESS. McArdle and colleagues showed an ESS>10 independently predicted long-term 
CPAP use (HR 1.98, p<0.001) (McArdle, 1999) (Table 3.) 
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Table 3: Different factors affecting CPAP compliance 
 
Author Type of study/ duration/ 
Number of participants 
Average CPAP use Positive 
associations 
Negative associations 
Waldhorn  
RE 
Retrospective/3 yr/96 N/A but only 73 
(76%) continued 
CPAP at 14.5 mo 
Positive: severe 
subjective daytime 
sleepiness; 
negative: previous 
palatal surgery 
Baseline AHI or sleep 
staging, AHI or sleep 
staging on CPAP, CPAP side 
effects 
Krieger J Prospective/874 d/214 5.6 ± 0.1 (SE) run 
time 
AHI, AI, minimal 
Sao2, day Pao2, 
pulmonary artery 
pressure 
 
Meurice JC Prospective/14 mo/44 6.0 ± 2.5 (SD) run 
time 
Initial AHI, % light 
sleep and % deep 
sleep, improvement 
in AHI, mean Sao2 
and hypersomnia 
score 
CPAP side effects 
Engleman 
HM 
Prospective/3 mo/54 4.7 ± 0.4 (SE) run 
time, 4.2 effective 
time 
CPAP side effects AHI, MSLT, ΔMSLT 
Kribbs  NB Prospective/3 mo/35 4.9 ± 2.0 (SD) 
effective time 
Satisfaction with 
CPAP, daily energy 
level at follow-up 
AHI, minimum Sao2, MSLT 
Reeves-
Hoche MK  
Prospective/6 mo/38 4.7 run time, 4.3 
effective time 
High AHI correlated 
with effective mask 
pressure 
AHI, age, gender, BMI, 
weight loss, education 
level 
Engleman 
HM 
Retrospective/632 d/204 5.1 ± 2.5 (SD) run 
time 
Positive: ESS, 
improvement in 
nocturnal symptoms 
and daytime 
function, negative: 
CPAP-related 
awakenings, noise, 
and sore eyes 
AHI, CPAP mask leak, and 
rubbing, dry throat/nasal 
stuffiness 
Krieger J Prospective/1,176 d/575 5.7 ± 1.8 (SD) run 
time 
Positive: age, BMI, 
and AHI, negative: 
Day Pao2, FEV1, and 
FVC 
Symptoms of OSA and 
CPAP side effects 
Pieters T  Retrospective/784 d/84 5.0 ± 1.8 (SD) run 
time 
Positive: Movement 
arousal index, 
negative: age, mean 
Sao2 during non-
REM sleep 
 
Likar LL  
 
 
 
Retrospective/1,151 d/34 5.2 ± 0.5 (SE) (pre-
clinic), 6.3 ± 0.6 
(SE) (post clinic) 
run time 
Group CPAP clinic 
education (four 
sessions) 
 
Hoy CJ Prospective RCT/6 mo/intensive 
support (n = 40) vs standard 
support (n = 40) 
5.4 ± 0.3 (SE) 
(intensive) vs 3.9 
± 0.4 (SE) 
(standard) 
effective time 
Intensive support 
(additional nursing 
input, 3 nights CPAP 
titration, and home 
visits), self-referral 
Duration of CPAP therapy 
McArdle N Prospective/median 22 
mo/1,155 
Median 5.7 run 
time 
Snoring, AHI, ESS, 
average CPAP use 
within the first 3 mo 
 
Pepin JL 
 
 
Prospective/3 mo/(A) n = 63 
CPAP with run time vs (B) n = 58 
CPAP with both run time and 
effective time 
5.1 (group A), 5.8 
(group B) run time 
Improvement of 
nocturia and 
subjective sleep 
disruption 
Age, BMI, Pao2, Paco2, 
FEV1, VC, initial AHI and 
AHI with CPAP, CPAP level, 
improvement of snoring 
and daytime sleepiness, 
CPAP side effects 
Noseda A Prospective/4 mo/106 4.9 effective time Positive: early 
bedtime, negative: 
Minimum or mean 
Sao2, % of slow-
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wave sleep 
Wolkove N  Retrospective/ 4 years/ 80  Sleep apnoea 
related symptoms 
 
Kohler M Retrospective 6.2 ODI ESS, Gender, Age, Neck 
circumference 
Chai-
Coetzer CL  
Prospective / 12 month/ 275 3.3 +_2.4 Side effects at 1 
month 
 
 
 
 1.2.3    Treatment related factors 
  
1.2.3.1   Initiation of CPAP    
Initial experiences with CPAP are known to predict the subsequent compliance 
(Budhiraja R, 2007). In a prospective study, only 26% of patients who used CPAP sub-
optimally on day 3, used it more than 4 hours on day 30.  Side effects of CPAP were 
common, being reported by 30-70% of the patients started on the treatment 
(Hoffstein V, 1992; Engleman HM, 2003; Grunstein RR, 1995). CPAP users reported 
having a dry mouth (40%), nasal symptoms (31%), poor mask fitting/ leaks (28%) and 
skin irritation or soreness (17%). Others were inconvenienced by the noise, eye 
problems and claustrophobia (Chai Coetzer CL, 2013).  Conversely, Engleman et al 
found optimal CPAP usage in individuals who did not report any side effects 
(Engleman HM, 2003), though this association with reported side effects has not been 
observed consistently across other groups of patients (Hoffstein V, 1992; Hui DS, 
2001; Engleman HM, 1996). Indeed, it is reported that health care personnel may 
perceive side effects to be more of a problem than patients do (Brostorm A, 2009). 
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1.2.3.2   Titration 
Since the introduction of CPAP to treat OSA was first reported by Sullivan (Sullivan CE, 
1983), a range of methods of CPAP titration have been employed with practice varying 
widely in different centres.  
Among the various ways in which CPAP titration can be performed are: 
1. Attended in hospital or unattended at home 
2. Full night or split night 
3. In the daytime or at night 
4. Automatic or manual or with the pressure established according to a formula 
According to the AASM taskforce, CPAP titration for patients >12 years of age (full or 
split night) involves the application of CPAP starting at a low pressure (i.e. 5 cm H2O) 
and upward titration of pressures at ≥ 1-cm increments over ≥ 5-min periods. The  
titration goal is usually to abolish apnoeas or hypopneas, snoring and respiratory 
effort related arousals by maintaining airway patency, in all the body positions and 
sleep stages. These are continued until ≥ 30 min without apnoeic events is achieved. 
Higher starting CPAP may be used in individuals with high BMI or those requiring re-
titration studies. Abolishing these sleep related breathing events by optimal CPAP 
titration should lead to an uninterrupted and refreshing sleep and hence improved 
daytime / nocturnal symptoms.  
Attended polysomnography has been proposed to be the gold standard for PAP 
titration as it allows sleep stage and determination of arousals and body position 
(Kushida CA, 2008). However, it is a resource intensive approach as it requires 
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admission to the sleep laboratory for a night and a trained polysomnographer is 
needed to institute the titration during the night. Not only is this approach associated 
with higher financial costs, its effectiveness has been questioned especially due to the 
availability of effective and good alternative options (Masa JF, 2004).  
The alternatives include split night studies or unattended home titration with an auto 
titrating CPAP. Split night studies involve admitting patients to the sleep laboratory. 
During the first half of the study, a diagnostic sleep test is performed. This is either a 
full polysomnography or limited channel respiratory sleep diagnostic test. If it 
confirms the diagnosis of OSA, then the sleep physiologist starts the patient on CPAP 
to prevent upper airway collapse, aiming to abolish apnoea/ hypopnoea as well as 
sleep related arousals. Pressures are gradually titrated till the desired physiological 
responses are achieved. Patients are then sent home on the fixed nasal CPAP settings 
achieved during the night of the study.  With either of these approaches, the pattern 
is set on a single night or half night and cannot accommodate night-to-night 
variability. 
Auto CPAP titration is another way to achieve the required therapeutic positive airway 
pressure. There is significant night-to-night variability in OSA severity with changes 
due to the patient’s position, alcohol consumption and sleep quality among other 
factors (White LH, 2015). Auto CPAP is designed to detect flow changes and 
obstruction through the night. The delivered pressure is then adjusted to stop these 
events. This strategy allows the patient to initiate treatment as an outpatient. Both 
home studies and split night studies have been found to be cost effective as well as 
clinically effective alternatives to attended laboratory studies. There is, in addition, 
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good evidence that auto CPAP is an effective option alternative with short and the 
long-term compliance which is comparable to that achieved by patients who have had 
an inpatient titration (Skomro RP, 2010; Noseda A, 2004; Desai H, 2009). 
Full night vs. Split night:  A full night titration involves a diagnostic sleep test on one 
night, which could be home or hospital based, followed by CPAP titration for a full 
night as an inpatient. Most studies of this approach have shown no difference in 
compliance or initial acceptance between a full night and split night titration (McArdle 
N, 2000, Yamashiro Y, 1995). In a cohort study matching patients on split night and 
full night PSG, no difference was observed in the initial acceptance and adherence 
rate when patients were followed up for 22 – 27 months (McArdle N, 2000).  A case 
control study found no difference in compliance and acceptance at 4-6 weeks (Strollo 
PJ  1996), a result reproduced by others (Fleury B 1994; Sanders MH 2000).  
Daytime vs. full night:  In a cohort study comparing daytime vs. night time titration, 
no significant difference was observed in the final CPAP level, or the number of 
failures of treatment. After 12 weeks there was no difference in the number of 
patients not on CPAP or in those with self-reported CPAP use more than 5 nights per 
week (Rudkowski JC, 2001). In another smaller study of subjects with severe OSA, no 
differences were observed in average compliance or objectively measured number of 
nights CPAP was used, though the two groups were only followed for one week 
(Rosenthal L, 1998). A prospective study looked at the long-term uptake and 
compliance when OSA was diagnosed via limited sleep studies followed by daytime 
titration of the CPAP level) (Johnson MK, 2004). At a median follow up of 23 months 
the median CPAP usage was 5.3 hours per night. Seventy-seven percent of patients 
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were still using CPAP at 3 years. Another prospective study involving 93 consecutive 
patients with OSA, CPAP pressure was significantly lower with conventional night-
time or daytime manual titration compared to automatic daytime titration (7.5 cm, 
7.4 cm and 9.4 cm respectively p 0.001). However, usage and improvement in daytime 
sleepiness were similar in the three groups (Loberes P, 2004).  
Manual vs. Automatic titration (Auto-PAP)/ unattended home titration:  
By virtue of their capability of changing pressure to a minimal delivered one to control 
sleep apnoea it was initially hypothesised that Auto PAP would lead to improved 
compliance. However experimental studies (discussed in the next section) have failed 
to show any significant beneficial effects in improving short and long-term 
compliance. Not only is Auto PAP used as a treatment modality, it is also used as a 
titration device to establish the best-fixed pressure required to control apnoeas and 
hypopneas. Masa et al in a randomised study of 315 patients compared Auto PAP with 
standard manual titration and with a predicted formula titration. No difference was 
observed between any of the 3 methods in controlling OSA or in the patients’ average 
compliance with CPAP after titration (Masa JF, 2004). Similar observations have been 
made in other experimental studies (Stradling J, 1997; Berkani M, 1998; Mulgrew AT, 
2007). 
1.2.3.3   Modes of delivering positive airway pressure 
Often the reason cited by patients for their inability to use CPAP is either problem 
with the interface (mask leaks, mask allergy, skin abrasion, claustrophobia), 
humidification (air dry or cold), pressure (too much pressure, mask leaks, rhinitis, 
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rhinorrhoea, aerophagia, difficulty exhaling) or equipment (noise, smell, tubing 
condensation, spousal intolerance).  
In an attempt to improve patient tolerance with positive airway pressure treatment, 
alternative devices, which deliver pressure to the airway in a different way to 
conventional fixed pressure CPAP, have been developed. These include Auto PAP, Bi-
level PAP, Expiratory relief PAP (C-Flex) and Bi-Flex. 
Auto-PAP: delivers variable pressure through the night to control the apnoeic and 
hypopnoea events.  Auto-PAP works with the principle of either detecting changes in 
“flow” or changes in “impedance”. An algorithm in the device leads it to respond to 
variation in respiratory flow, flattening of inspiratory flow contour or snoring 
(Stradling JR, 1997; Lloberes P, 1996; D’Ortho MP, 2000).  More recent devices have 
an algorithm that responds to changes in airway resistance and impedance with the 
aid of forced oscillation technique (APAP FOT) (Ficker JH, 2003). Once the devices 
detect the differences in these respiratory parameters, they generate pressures 
aiming to overcome the obstruction. This dynamic process leads to delivery of variable 
pressure through the night rather than a fixed pressure as delivered by CPAP. Clinical 
use can be limited by the inability of Flow devices to discriminate between central and 
obstructive events, when there is complete cessation of flow. Also, devices based on 
impedance alone cannot detect leakages or increases of upper airway resistance, 
resulting in generation of higher pressures than needed (Stamnitz A 2004).  
Though the pressure generated during the night to control obstructive events is lower 
with the Auto-CPAP, this is not translated into an improved effectiveness or 
compliance on treatment. In a meta-analysis, which looked at 9 available randomised 
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trials, Auto-PAP was not found to have any advantage over fixed CPAP in reducing AHI 
(Ayas NT 2004).  
Another meta-analysis looked at the impact of pressure modification in improving 
CPAP usage in OSA patients (Smith IE 2009).  Forty-five studies were reviewed 
including 30 using Auto CPAP (1136 participants). A small but statistically significant 
improvement in CPAP usage was observed in the Auto CPAP group (0.21 hours per 
night). However, the clinical significance of this small improvement in hours of use is 
questionable.  Parallel group studies found no differences in the ESS score in different 
groups though crossover studies showed an improvement in ESS (O.64 units, -0.12- -
1.16) in the Auto PAP group. Where measured, participants preferred to take Auto 
PAP home compared to standard CPAP (Smith IE 2009)  
Bi-level-PAP: delivers different but fixed pressures during inhalation and exhalation, 
and can be used as alternative therapy in OSA patients. There are only a few published 
studies comparing this mode of PAP delivery with the fixed CPAP. Though it was found 
to be as effective as CPAP in treating OSA, no differences in efficacy or compliance 
with the treatment were observed in unselected populations (Reeves-Hoche MK, 
1995; Laursen SB, 1998, Gay PC, 2003).  Despite of this lack of clear evidence of benefit 
this mode continues to be used in clinical practice in a selected population of 
individuals with OSA struggling with CPAP mainly due to pressure intolerance (Smith 
IE, 2009). Another trial used a modified Bi-level device (Bi-flex), with reduced pressure 
at the end of inspiration and slightly reduced pressure near the beginning of 
expiration and compared this with CPAP in a randomised fashion. At 1 month no 
differences in compliance were observed between the two different modes. 
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Improvements in ESS and functional outcomes of sleep questionnaire were also 
similar for the two devices (Gay PC, 2003).  
Expiratory relief PAP (C-FLEX): is another way of delivering positive airway pressure 
where the pressure is reduced at the beginning of expiration on a breath-by-breath 
basis in proportion to the person’s expiratory flow rate. This drop makes exhalation 
easier compared to CPAP. The maximum pressure drop with this mode is 3.0 cm. 
Towards the end of expiration, the pressure increases and theoretically the optimal 
pneumatic splint is maintained so as to prevent airway collapse. It has been 
hypothesised that by reducing the pressure at the beginning of expiration, it should 
make it easier for the patient to tolerate PAP and hence improve compliance. 
However, other studies have yielded conflicting results. In a randomised crossover 
study, though the expiratory relief mode was found to be as effective as fixed CPAP, 
compliance was no different (Nillius G, 2006). No significant differences were 
observed in objective daytime sleepiness and simple response time (psychomotor 
vigilance test) between the two devices. In a longitudinal study, by Dolan et al, 
Expiratory Relief-PAP (ER-PAP) was associated with greater mask comfort on visual 
analogue scales while overall compliance and subjective sleepiness were not superior 
to CPAP therapy (Dolan DC, 2009). In a small prospective single blind cross over study 
involving 20 patients with OSA who were followed up for 3 years, ER-PAP was noted 
to be associated with identical short term compliance compared to CPAP (Wenzel M, 
2007). 
A-Flex: is a further modification of C-FLEX technology. During the expiratory phase of 
the respiratory cycle, it works in the same way as ER-PAP. However, it also aims to 
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soften the pressure transition from inhalation to exhalation by increasing the pressure 
delivered more gradually to better mirror the normal breathing rhythm of the CPAP 
user.  In a randomised double blind 3 arm study comparing A-Flex with CPAP and Auto 
CPAP, A-Flex was noted to be equivalent to other devices in terms of efficacy, 
compliance and functional outcomes measured by FOSQ, ESS and Psychomotor 
vigilance test. (Kushida CA, 2011). 
1.2.3.4   Interface 
 
Approximately two thirds of patients will experience side effects from CPAP including 
nasal stuffiness/ congestion, skin irritation, eye puffiness, or gastric fullness 
(Engleman HM, 2003). Yet, side effects of the treatment have not been shown to be 
predictive of adherence to CPAP (Kribbs NB 1993b; Engleman HM, 2003; Rauscher H, 
1993; Waldhorn RE, 1990; Fletcher EC, 1991; Hoffstein V, 1992). Indeed, it has been 
shown in one study that individuals who reported mask-side effects were in fact those 
patients who used CPAP regularly (Weaver T, 1997). 
There is some evidence that nasal resistance can affect initial acceptance and 
subsequent compliance with CPAP. Smaller nasal cross-sectional area and reduced 
volume, measured with acoustic rhinometry, were associated with non-adherence 
(Hy Li, 2005). Nasal surgery in individuals who were intolerant of CPAP and nasal 
symptoms with nasal resistance resulted in improved CPAP tolerance post-operatively 
(Nakata S, 2005) 
1.2.3.5   Humidification 
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Humidification is used to improve patient comfort on CPAP treatment when patients 
report drying of the airway. However, its effectiveness in improving CPAP compliance 
is not clearly established. In a randomised crossover trial patients were treated with 
heated humidification, cold pass-over humidification and had a washout period 
without humidification. The heated humidifier increased adherence to CPAP 
compared to either cold pass-over humidifiers or no humidification and specific side 
effects such as dry mouth or throat and dry nose were reported less frequently when 
CPAP was used with heated humidity compared to CPAP use without humidity (p < 
0.001). Interestingly, heated or cold pass-over humidifiers when compared to no 
humidification equally improved subjective patient satisfaction with treatment 
(Massie CA, 1999). Another randomised crossover study involving 37 patients 
demonstrated a small improvement in adherence with CPAP with heated 
humidification, but no difference in subjective sleepiness or treatment satisfaction 
(Neil AM, 2003). A trial, involving 125 patients, randomised new CPAP starters to CPAP 
alone, humidified CPAP or CPAP with topical nasal steroids over a 4-week period. The 
addition of a humidifier, but not nasal steroids reduced the frequency of nasal 
symptoms, however no changes were observed in compliance or measures of quality 
of life (Ryan S, 2009).  
Overall, whilst humidifiers are noted to reduce side effects and improve comfort in 
individuals with OSA. They are not associated with an improvement in adherence and 
compliance when used unselectively in a population of patients with OSA started on 
CPAP for the first time. 
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1.2.4   Socio-demographic factors 
1.2.4.1   Sex 
 
In contrast to men, women have different polysomnographic findings for the same 
degree of symptoms, with lower AHI’s and more episodes of airway resistance 
without complete obstruction. Women diagnosed with OSA are on average older and 
more obese than the men in the same clinic and can present differently having more 
symptoms of lack of energy, depression, insomnia and morning headache (Kapsimalis 
F, 2002; Quintana-Gallego 2004; Vagiakis E, 2006; Smith R, 2002; Tarasiuk A, 2004; 
Guilleminault C, 1995). Conflicting results have been found when adherence / 
compliance with CPAP is compared between the sexes. Sin et al in their observational 
study of new CPAP starters who were followed up for 6 months, found that women 
on average used CPAP more than men (Sin DD, 2002) While Fleury et al in their study 
found female sex to be associated with poor compliance with CPAP (OR 2.8, p value 
0.02) (Fleury B, 2001). McArdle et al in their prospective observational study looking 
at long-term compliance of 1255 patients with OSA found that female sex was more 
often associated with refusal to accept CPAP treatment (32% women refused to use 
CPAP compared to 14% men), however there were no differences in the subsequent 
compliance with CPAP (McArdle N, 1999). Another retrospective study found older 
males to be associated with optimal CPAP compliance at 1 year (Somners ML 2011). 
Most of the other studies have found no correlation between female sex and 
compliance with CPAP (McArdle N, 1999; Lewis K, 2004; Lin HS, 2007). Overall no 
consistent association has been found between sex and CPAP compliance. 
48 
 
1.2.4.2    Socio-economic status 
 
As per the national standard for educational statistics definition “Socioeconomic 
status (SES) is an economic and sociological combined total measure of a person's 
work experience and of an individual's or family's economic and social position in 
relation to others, based on income, education, and occupation (National centre for 
Educational statistics 2008).  
The NS-SEC in the UK is another way of defining the socio-economic class. It does not 
take income into account and is rather constructed to measure the employment 
relations and conditions of occupations (Goldthorpe, 2007). Conceptually, these are 
central to showing the structure of socio-economic positions in modern societies and 
helping to explain variations in social behaviour and other social phenomena. It has 
also been validated both as a measurement tool and as a good predictor of health, 
educational and many other outcomes (NS-SEC 2010). 
Low socio-economic status (SES), irrespective of whether it is classified on income, 
education, profession or a combination of these, is linked with an increased risk of 
mortality and morbidity from cardiovascular illness (Symes SL, 1976; Grafstein O, 
1989; Lynch JW, 1998; Salomm V, 2000). It is also associated with higher prevalence 
of chronic illnesses including COPD, Asthma, Depression and cardiovascular disease 
(Lorant V, 2003; Clark AM, 2009). Not only is the prevalence of chronic illness high 
amongst this group, they also have lower health related quality of life. (Kanervisto 
M2011; Kreiger N, 2001; Cohen BH, 1977; Viegi G, 2001; Hesselink HE, 2006).  Patients 
with lower SES have been shown to have a greater exposure to risk behaviour, 
including poor compliance with medications and non-attendance for health checks 
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ups (Mackenbach JP, 2006).  In a cross sectional, population based study involving 
13603 men and 18292 women; socioeconomic disadvantage was associated with non-
adherence to medications independent of long-term illness (Wamala S, 2007).  
There is evidence that low SES could be a risk factor for cardiovascular diseases in 
adult OSA patients. In a prospective study involving 1019 patients with OSA, low SES 
judged by income compared to national average income (low income<20% of national 
average, average income +/- 20% of national average and high income >20% of 
national average), was found to be an independent risk factor for cardiovascular 
diseases amongst patients with OSA. For each decrease in income level category there 
was a 40% increase in the risk of cardiovascular disease (Tarasiuk A, 2006).  
To date there are a very few studies looking at the role of SES in acceptance and 
compliance with CPAP treatment in patients with OSA. One cross sectional study 
looking at the pattern of acceptance and adherence of CPAP in an Israeli population 
found the likelihood of CPAP purchase to be determined by income level (OR 2.4, 
95%CI 1.3- 4.3) (Simon-Tuval T, 2009). Following a 2-week adaptation period after 
starting CPAP treatment, 22% of individuals with low income accepted and purchased 
CPAP compared to 51% and 76% from average and high-income groups respectively. 
The authors proposed that CPAP acceptance in relation to SES is linked to access and 
cost of care with individuals with low SES, not being able to afford or access it. Twenty-
nine percent of patients in this study, who refused CPAP treatment, reported cost as 
the reason. However, the association between SES and CPAP acceptance and 
adherence is not consistent.  
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In a study in Belgium, socio-economic background as assessed by the educational 
status did not correlate with CPAP compliance. The same group looked at an 
association between compliance and status as an employer versus employee. 
Compliance was found to be similar in the two groups (Verbraecken J, 2007).  In a 
questionnaire based, retrospective study looking at a population of OSA patients in a 
public and a private hospital, who were commenced on CPAP within the past 6-15 
months, no differences in compliance was observed in relation to the income category 
or the educational status. The limitation of this study was that it was retrospective, 
with a small number of patients and compliance was the patient’s own estimate 
rather than more accurate objective measurement on the CPAP (Welfare M, 1997). In 
another retrospective chart review, 42% of patients from an institution serving a 
minority population (largely lower income, uninsured people) failed to turn up for 
follow-up of CPAP treatment. In comparison 7% in a voluntary hospital group cohort 
(mainly middle class and health insured people) failed to turn up (Greenberg H, 2004). 
A similar study evaluating the relationship between CPAP adherence and race/ other 
socio-demographic factors in a publicly funded hospital in the US found that African 
Americans were more likely to be adherent than Caucasians (OR 5.02, 95%CI, 1.59-
15.84) (Joo MJ, 2007). One limitation of this study was that the number of Caucasians 
was relatively small compared to number of the African Americans (18 versus 196).  
Co-existence of Mood disorders 
Poor socio-economic status may also be associated with chronic depression and 
anxiety, (Lorant V, 2003; Murphy J, 1991) which have been noted to influence 
compliance on CPAP therapy (Lewis KE, 2004; Edinger JD, 1994). 
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A study in New Zealand (looked at the association between CPAP compliance and 
Socioeconomic / Ethnic status (Bakker JP, 2011). Maori ethnicity was associated with 
slightly lower CPAP adherence (median CPAP use 5.11 hours’ vs. 5.71 hours in non- 
Maori population). On further multivariate analysis taking into account ethnicity, 
eligibility for government-subsidised healthcare, individual deprivation scores, 
income and education; the factors of non-completion of tertiary education and high 
individual socioeconomic deprivation scores remained significant independent 
predictors of average CPAP adherence not reaching 4 hours (Bakker JP, 2011). 
One limitation in most of these studies looking for an association between SES with 
CPAP acceptance and compliance is that all (other than the Campbell and Verbraecken 
study) were done in health care systems where the individuals either purchased their 
own CPAP machine or needed to be insured (Joo MJ, 2007; Campbell AJ, 2012; Bakker 
JP, 2011; Greenberg H, 2004). Though Simon-Tuval’s study tried to address this issue 
by giving free access to initial CPAP titration and subsequent 2-week adaptation to all 
the participants, patients still had to purchase the equipment at the end of the trial 
period, which may have been the reason for the poor acceptance in the lower income 
group (Simon-Tuval T, 2009).  
Another limitation in most of these studies is that they have used income as the sole 
factor to determine the SES of an individual.  An individual’s occupation is likely to be 
as important a measure of SES as income (National statistics socio-economic 
classification 2001, office of national statistics). This has formed the basis of 
socioeconomic classification in many countries including United Kingdom and New 
Zealand. The National statistics socio-economic classification (NS-SEC), uses an 
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individual’s profession or occupation to derive socio-economic class. There are 5-8 
classes, depending on whether the SEC is derived by a self-coded (Appendix-2) or by 
a more structured interviewer coded method. Though the interviewer coded method 
is more sensitive, it is more time consuming. For purposes of ease and brevity of use 
the self-coded version is commonly employed. To derive socioeconomic class, four 
structured questions related to employment, structure of the organisation, 
supervisory status and occupation are asked. The responses to these questions create 
an employment and occupation variable, which when fed into a vector helps to derive 
the socio-economic class (Table 4). 
 
                      Table 4: Five class SEC classification 
 
Class Label 
1 Managerial and professional occupations 
2 Intermediate occupations 
3 Small employers and own account workers 
4 Lower supervisory and technical occupations 
5 Semi-routine and routine occupations 
 
So far there is no consensus on the role of socio-economic status in CPAP acceptance 
and compliance in OSA. Most of the studies done in countries where CPAP treatment 
is funded privately have shown poor uptake and compliance in individuals with low 
income. Relationship between the two is however not very clear as there are many 
confounding factors including higher incidence of anxiety/ depression in low SEC 
group as well as poor access to treatment.  
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As highlighted earlier there were likely a few limitations in most of the previous 
studies. SES was solely derived from income and most were done in privately funded 
health systems (either partial or full private) meaning that the results cannot be 
readily extrapolated to the NHS in the UK.   
In the National Health Service of the United Kingdom (NHS UK), delivery of most care 
is free at the point of delivery (prescriptions are an exception) and access to any 
treatment is not dependent on income or health insurance. This helps to avoid the 
bias inherent in the previous studies, which have looked at the relationship between 
the SES and CPAP compliance.         
1.2.5     Psychological factors 
1.2.5.1   Type D personality 
 
This personality construct was identified while looking at the coping styles in 
individuals with coronary artery disease (Denollet J, 1995). The type D construct 
describes individuals who have a tendency to experience high levels of negative 
emotion (negative affectivity) and inhibit these emotions while avoiding social contact 
with people (social inhibition). Across time and situations these individuals not only 
experience negative emotions (anxiety, sadness, anger and hostile feelings), they also 
inhibit the expression of these emotions in social interaction due to fears of how 
others may react. They tend to feel inhibited, tense, insecure and uncomfortable 
when they interact with other people. They not only have significant negative 
affectivity but also lack the coping mechanism to deal with it. Both negative affectivity 
and social inhibition are associated with the perception of a socially unsupportive 
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environment (Pedersen SS, 2004) and they perceive the external world as threatening 
(Asendorpf JB, 1993). 
Type D personality alone, has been associated with poor outcomes in patients with 
underlying cardiac illness (Denollet J, 2000). Poor self-management, social inhibition 
and inadequate consultation in individuals with Type D personality could perhaps lead 
to a lack of adherence with the treatment for chronic medical and surgical illnesses, 
including the treatment of obstructive sleep apnoea with CPAP.  
In a cross- sectional study of 247 patients with OSA of variable severity (AHI 30 to 98 
/hour), who were on CPAP treatment for 6-182 months there was a significant 
difference in CPAP compliance patterns between individuals with Type D personality, 
compared to those without it. People with Type D personality used CPAP on average 
1 hour 20 minutes less than those without the trait. Only 50% of individuals used CPAP 
>4 hours per night, compared to 84% of the non-type D personality (Brostrom A, 
2007). One limitation of this study was that it was a retrospective, cross-sectional 
analysis, with patients included already on CPAP treatment for a variable period of 
time. Reviewing the literature, there are no prospective studies, which have looked at 
association between Type D personality and CPAP compliance.  
1.2.5.2    Depression 
The prevalence of depression is higher in individuals with OSA than the general 
population. In a prospective study of patients with severe OSA, the prevalence of 
depression defined as Zung self-rated depression score >50, was 48% (Akashiba T, 
2002). Using the Minnesotta multiphasic personality inventory, Aikens et al found that 
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32% of patients with OSA had raised MMPI scores (Aikens JE, 1999a). Another study 
by the same group found that compared to age and sex matched primary snorers, 
there were twice as many OSA patients with raised MMPI scores (Aikens JE, 1999b).  
Using Beck’s depression inventory- (BDI) fast score to assess severity of depression, 
another group found 41% of their patients with OSA had at least mild depression and 
12% had moderate to severe depression (Schwartz DJ, 2007). In comparison the 
prevalence of major depression was 2-4% of in the community, 5-10% in primary care 
patients and 10-14% in medical inpatients. Although the majority of studies have 
found an association between depression and OSA, in a longitudinal study over a 5-
year period, depressive symptoms were not found to be any different in patients with 
mild OSA (Phillips BA, 1996; Chervin RD, 2003; Pillar G, 2004). 
Some of the symptoms of OSA including excessive daytime sleepiness, fatigue, mood 
changes, irritability, lack of concentration and poor motivation may be perceived by 
patients, as well as by the physician’s treating them as due to depression rather than 
OSA (Chervin RD, 2003). These symptoms, overlapping between depression and OSA 
are more commonly reported by women than men (Pillar G, 2004). 
Depression scores, in individuals with OSA, can improve on CPAP treatment. In a 
prospective study of 50 patients with OSA (RDI 57.4 ± 31.1), the BDI improved 
significantly after CPAP treatment. This improvement was seen irrespective of 
whether they were on antidepressants (Schawartz DJ, 2007). Another study of 39 
patients with OSA, showed an improvement in somatic and affective/ cognitive 
symptoms of depression as assessed by BDI 1-3 months after CPAP therapy (Means 
56 
 
MK, 2003).  It was suggested that depressive symptoms in these individuals were not 
due to physical symptoms, but a mood component of OSA.  
The improvement was however not seen consistently. In a study involving 80 patients 
with OSA, no improvement in BDI scores was seen at 3 and 12 months on CPAP 
treatment (Munoz A, 2000). In another randomised, double- blind, placebo controlled 
trial using sub-therapeutic CPAP as a control, no improvement in the geriatric 
depression scale was seen in therapeutic CPAP group compared to the controls 
(Henke KG, 2001).  
Depression can be associated with poor adherence to therapy in other chronic 
medical disorders (Smith A, 2006; Bosley CM, 1995). In patients with OSA, there is 
conflicting evidence regarding an association between underlying depression and 
CPAP use. In a prospective study involving 70 patients, there was no correlation 
between CPAP compliance and underlying depression measured by the Hospital 
Anxiety and Depression scores (Lewis KE, 2004). In a study using the Minnesota 
Multiphasic Personality Inventory to measure depression, individuals who were 
depressed had poor CPAP compliance compared to those who were not depressed 
(Edinger JD, 1994). 
To summarise, it is not certain whether depression is more common in people with 
OSA than the general population or if overlapping symptoms lead to an over-diagnosis 
of depression. Similarly, it is not known whether depression impacts on compliance 
with CPAP therapy.  
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 1.2.5.3   Anxiety 
 
Anxiety is reported frequently in patients with OSA. Eleven to 28% of OSA patients 
complain of claustrophobic feelings as well (Edinger JD, 1994, Lewis KE 2004; 
Stepnowsky CJ, 2002; Lewis KE, 2004). Anxiety is associated with sub-optimal 
compliance in other chronic medical conditions (Bosley CM, 2004). Anxiety and 
personal coping strategies have been found to affect CPAP compliance (Budhiraja R, 
2015). However, this association has not been found consistently. A prospective 
cohort study monitoring HADS (Hospital Anxiety and Depression scale) as a measure 
of anxiety found no association between anxiety and subsequent CPAP usage (Lewis 
KE, 2004).  
1.2.6   Educational and behavioural factors 
 
Information and knowledge about OSA and recognising the importance of adhering 
to CPAP is associated with improved acceptance and compliance with the treatment.  
Different studies have reinforced the importance of behavioural and educational 
interventions in improving health outcomes by recognising the benefits and 
effectiveness of the treatment. These interventions include: 
 Individual educational session delivered by a nurse 2 weeks after commencing 
CPAP, short (10-20 minutes) educational videotape on OSA (Bosoglu 2011ef) 
 Face-to-face education sessions delivered by a trained nurse one and two 
weeks after initiation (Aloia MS, 2012). 
 Group teaching session (Epstein L, 2000; Wang W, 2012). 
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 Routine Information on diagnosis and treatment of OSA given by a physician, 
Telephone-linked communications technology (TLC) versus usual care, 
(DeMolles DA, 2004). 
  Given mask to try for 20 minutes, titration of CPAP pressure overnight with 
following day discharge, nurses telephoned on days two and 21, reviewed in 
hospital at one, three and six months (Hoy CJ, 1999).   
 Locally produced 15-minute videotape, additional nurse led 15-minute 
educational session, review by physicians at weeks one and two, respiratory 
nurse telephone call on days one and two, weeks one, two, four, eight and 12 
(Hui DS, 2000). 
 Initial education at home with partner, two extra nights in hospital, sleep 
nurses’ home visits to participant and partner at seven, 14 and 28 days and 
four months after starting CPAP. (Hoy CJ, 1999). 
 10-Minute CPAP education programme by respiratory nurse, brochure on OSA 
and CPAP treatment in Chinese, short trial CPAP therapy with comfortable 
mask for 30 minutes, CPAP titration on second night of study by Auto Set, 
nursing support following day, follow-up by nursing staff and physician at 1 
and 3 months. (Hui DS, 2000). 
 Motivational Enhancement Therapy (MET) sessions delivered by a trained 
nurse one and two weeks after initiation of treatment. An extra phone call at 
week three. These sessions consisted of individually tailored counselling (Aloia 
MS, 2004).  
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These educational interventions were found to be associated with a small increase in 
CPAP use of about 35 minutes per night (0.60 hours, 95% CI 0.27 to 0.93 in a meta-
analysis (Wozniak DR, 2014). Behavioural interventions increased average CPAP use 
by 1.44 hours per night (95% CI 0.43 to 2.45). There was a higher likelihood of 
participants in the educational intervention group using CPAP optimally. Interventions 
influencing decisional balance in favour of CPAP or those promoting self-efficacy and 
outcome expectations were associated with an improvement in health behaviour 
outcomes. 
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1.3   LONG TERM COMPLIANCE WITH CPAP 
 
In a cost effectiveness model appraised by NICE, it was suggested that the CPAP 
treatment dominated “non- treatment” after a minimum of 2 years. That is the cost 
of treatment is more than offset by savings produced by a reduction in the cost that 
would have accrued due to management of the adverse effects of OSA. CPAP 
treatment used long-term was also associated with an increase in quality adjusted life 
years (QALY’s) (NICE technology appraisal, 2008). 
There are a few published studies reporting long-term compliance with CPAP. In one 
of the early studies looking at this question, acceptance of CPAP treatment was 
greater than 90% at 3 years and greater than 85% at 7 years (Kreiger J, 1996). Hours 
of use correlated positively with age, body mass index, and AHI, and negatively with 
daytime partial pressure of oxygen (PaO2), forced expiratory volume in 1 second 
(FEV1), and vital capacity. This study shows that CPAP therapy may be accepted well 
by OSA patients as well as by non-apnoeic snorers. It was the objective disease 
severity (as measured by the respiratory event index and daytime and night time 
hypoxemia), rather than patients' symptoms or complaints, which played a role in the 
compliance with treatment.  
 In a retrospective study, which looked at the CPAP use in a private hospital, higher 
BMI, higher prevalence of witnessed apnoea, higher ESS score at baseline and 
improvements in daytime activity and improvement in ESS score were associated with 
successful CPAP use beyond 12 months’ period after initial trial. CPAP induced sleep 
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disturbance was associated with non- compliance with CPAP therapy (Hussain SF, 
2015). 
In a single centre experience only 65% of patients with OSA who were recommended 
to go on CPAP treatment, accepted treatment and of those who initially accepted 
treatment, only 53% continued with treatment at median 8-year follow-up (Cecila H, 
2006). In a study involving 648 patients, who were diagnosed with OSA and accepted 
CPAP, only 65% used CPAP more than 4 hours per night. Factors associated with 
optimal use were an improvement in daytime sleepiness and a positive effect of CPAP 
on sleep (Salepci B, 2013). 
A retrospective cohort study from Oxford, UK looked at long-term experiences with 
CPAP. It showed an adherence rates with CPAP at 5 and 10 years of 81% and 70% 
respectively (Kohler M, 2010). In their cohort of over 3500 patients with OSA who 
were commenced on CPAP, the median (IQR) follow-up time on CPAP was 3.9 (1.5-
6.9) years. Multivariate analysis suggested that the severity of sleep apnoea measured 
by overnight desaturation index rather than sleepiness, was the variable best 
associated with long- term adherence. 
In the SAVE study, it was found that CPAP use by patients with coexisting 
cardiovascular disease and moderate to severe OSA decreased significantly over 12 
months. Early patient experiences with CPAP (i.e., adherence and side effects at 1 
month) predicted subsequent use at 1 year (Chai- Coetzer CL, 2013). 
In a retrospective study of 80 patients who were started on CPAP 4 years earlier, 
patients with significant daytime sleepiness before they were commenced on the 
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treatment were more likely to be adherent to the treatment and show an 
improvement in the symptoms (Wolkove N, 2008). 
In summary, whilst initial symptoms (i.e. reports of excessive daytime sleepiness and 
a high ESS), severity of OSA and lack of initial side effects have been noted to be 
associated with better CPAP compliance, this association is not consistent and so is 
similar to the case with initial CPAP acceptance and short-term compliance.  
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1.4    HYPOTHESIS 
 
Acceptance of and subsequent optimal compliance with CPAP is key to its success in 
not only improving the symptoms and quality of life of patients with OSAHS, but 
potentially reducing the future cardiovascular risks.  So far there is no consistent 
association between demographics and disease severity related factors with CPAP 
compliance and acceptance.   
I set out with a series of studies, to look at the factors which may affect compliance 
with CPAP in those already on CPAP and also new CPAP starters. I hypothesised that 
underlying mood, personality disorder, socioeconomic status and physician’s initial 
impression whether a person is likely to use the treatment optimally or not can 
predict subsequent CPAP use. I also hypothesised that amongst the CPAP users, 
those who are unable to use the treatment optimally and complained of pressure 
related side effects, a change in device to a Bi-level positive airway pressure device, 
would improve their subsequent compliance. 
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1.5  AIMS 
 
The aim of the thesis was: 
 To explore the relationship between socio-demographic factors, type D 
personality and depression in predicting CPAP acceptance and compliance.  
 To further study the role of Bi-level PAP in patients sub-optimally compliant 
with CPAP due to pressure related side effects. 
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CHAPTER 2   STUDY DESIGN AND METHODS 
 
2.1    Long term compliance with CPAP- A single centre experience 
 
2.1.1   Study design 
This was a retrospective study of the long-term compliance with CPAP amongst 
patients of a single centre. Papworth hospital is a tertiary referral centre for 
individuals with sleep disorders. The unit opened in 1992, when the staff and patients 
transferred from Newmarket hospital in Suffolk, UK. CPAP treatment was already 
established at the centre at the time. From the sleep unit database and health records, 
we identified all individuals diagnosed with OSA with a nocturnal oxygen desaturation 
index (ODI) ≥5 who had started CPAP at Papworth Hospital between July 1995 and 
June 1998.  
2.1.2   Population 
Patients were referred to the sleep centre by both general practitioners and hospital 
doctors.  
2.1.2.1   Exclusions 
Patients with a neuromuscular disorder, those who had previously been treated for 
OSA with CPAP or an alternative device, those who were initiated on Bi-level positive 
airway pressure (PAP) for associated ventilatory failure, and those who had 
participated in related pharmaceutical trials were excluded from this study. 
Individuals where pre-treatment nocturnal oximetry traces were not available or 4% 
desaturation index was less than 5 per hour were excluded from the study. 
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2.1.2.2   Diagnosis 
Patients were diagnosed with OSA on the basis of characteristic symptoms and 
overnight arterial pulse oximetry criteria (> 5, 4% desaturation per hour-1) and 
Epworth Sleepiness Scale (ESS) score >10, Overnight oximetry was recorded on Datex 
Ohmeda 3740 oximeters (Datex-Ohmeda, Louisville, CO, USA) and printed using chart 
recorders.  
(a) The diagnosis of OSA in these cases was established on the basis of overnight 
oximetry that had a sensitivity of 97% and specificity of 80% in diagnosing 
sleep apnoea, when RDI of 10 per hour was used as a cut-off.  
(b) When the RDI was changed to 5 per hour, sensitivity and specificity changed 
to 100% and 43% respectively (Vazquez JC 2000). With the clinical information 
available at the time of review, there was an improvement in the diagnostic 
sensitivity. We used 5 per hour desaturation index as cut-off. This was based 
on the evidence available at that time as well as the standard practice at our 
centre.   
(c) Patients who were strongly suspected of having OSA but did not demonstrate 
oxygen desaturations on nocturnal oximetry were re-assessed by 
polysomnography (PSG). 
2.1.2.3   Monitoring 
Patients were monitored at least once a year, as per the local treatment policy unless, 
CPAP treatment was withdrawn, their care was transferred to another hospital, they 
stopped CPAP or failed to attend appointments. Monitoring comprised an outpatient 
or inpatient hospital visit where the patient's ESS score and weight were recorded and 
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average nightly CPAP use calculated from clock readings. Improved compliance was 
encouraged where necessary. Overnight oximetry whilst using CPAP was recorded at 
follow-up for at least 2 years and the CPAP level adjusted as required. Oximetry 
records were printed on chart recorders and analysed visually. Patients who remained 
excessively sleepy despite optimum CPAP therapy underwent further assessments. 
2.1.2.4   Ethics 
The study protocol was approved by the Huntingdon Local Research Ethics 
Committee, Cambridge, UK.  
2.1.2.5   Data collection/ Outcome measures 
The hospital records were reviewed between August and December 2003. One 
investigator (EM) re-analysed the overnight oximetry traces to identify mean and 
minimum oxygen saturation (SpO2) and calculate the oxygen desaturation index (ODI, 
≥4%) per hour.  The following were recorded: sex, age, ESS score, nocturnal oximetry 
data at diagnosis, date when CPAP was started, smoking status, BMI and documented 
history of cardiovascular disease, lung disease and diabetes. Compliance data were 
analysed (AG) during the period March-April 2008. Patients still using CPAP at the time 
their notes were reviewed or when they died were referred to as ‘CPAP users’. The 
latest nocturnal oximetry results, average nightly CPAP use, weight and ESS score 
whilst using CPAP were recorded for the ‘CPAP users’ that were still under follow up 
at Papworth Hospital (Papworth CPAP users).  
2.1.2.6   Outcome measures 
Primary – Long-term compliance on CPAP (average hours/ night) 
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Secondary - Association between age, sex, baseline ESS score, improvement in ESS on 
treatment, severity of OSA measured by desaturation index, anxiety, depression with 
CPAP compliance. 
2.1.3   Statistics 
Statistical analyses were performed using SPSS computer software version 15.0 (SPSS 
Inc, Chicago, IL, USA). For ‘Papworth CPAP users’ the latest treatment follow-up data 
were compared to the pre-treatment values and relationship with sex. Comparisons 
were made using Mann Whitney U and Chi-square test as appropriate. Odds ratios 
were calculated to identify the risk/ association between different variables with sub-
optimal compliance. 
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2.2    A prospective observational study to evaluate the effect of social, 
demographic factors and personality on CPAP compliance in OSA 
2.2.1   Aim 
 
I conducted a prospective study in newly diagnosed OSA patients to determine factors 
associated with acceptance and long-term compliance with the therapy.  
The physician’s estimation of the likelihood that the patient would accept CPAP 
treatment and subsequently comply with the treatment was measured on a visual 
analogue scale 0-100 at the time of recommending CPAP treatment to an individual. 
The staff were the medical team running the sleep clinics. This was a real life 
assessment and the team had a range of experience in managing patients with sleep 
disorders.  
FACTORS 
 Socio-economic status – Derived by national statistics socio-economic classification 
(NS-SEC), self-coded version (Appendix 2, 3). 
 Level of education (Appendix 3) 
 Type D personality – assessed by type D scale-14 (Appendix 4). In this pro-forma 2 
aspects of personality were assessed including social inhibition and negative 
affectivity. Individuals completed a DS 14 proforma. Those scoring greater than 10 in 
either domain were considered to be having a type D personality.  
 Depression – assessed by Beck’s depression inventory 2 (Appendix 5). 
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 Although the gold standard for diagnosing depression is a clinician’s assessment at 
the interview, there are several self-scoring assessment tools available for patients 
including the updated Beck Depression Inventory (Appendix 5). This is frequently used 
to detect depression and to assess responses to interventions. BDI 2 is a well-validated 
tool, which is positively correlated with the Hamilton Depression Rating Scale (a tool 
very closely related to clinical interview for diagnosing depression). There is a Pearson 
r of 0.71 between the two measures showing good agreement. The BDI 2 has also 
been shown to have a high one-week test–retest reliability (Pearson r =0.93) and high 
internal consistency (α = 0. 91). The 21-item survey is self-administered, and each item 
is scored on a scale of 0-3 against a list of four statements arranged to indicate 
increasing severity of depression. The BDI 2 is in alignment with DSM–IV criteria. The 
cut-offs used are: 0–13: minimal depression, 14–19: mild depression, 20–28: 
moderate depression, and 29–63: severe depression.  
 Sex 
 Sleep specific quality of life scores (sleep apnoea quality of life index-SAQLI) score 
(Appendix 6). 
 Epworth sleepiness scale score (ESS) (Appendix 1). A score of >10 is considered to be 
significant (Johns MW, 1991; Johns MW, 1997).  
 Severity of OSA as assessed by 4% oxygen desaturation index (ODI) (Vazquez zJC 
2000). 
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2.2.2   Ethics 
The Cambridgeshire 1 research and ethics committee 08/H0304/72 approved this 
study. The study was conducted during the period Dec 2007 to Jan 2009.  
2.2.3   Population 
 
All individuals referred to Respiratory Support and Sleep Centre (RSSC) with a 
suspected diagnosis of OSA was considered eligible for the study. The diagnosis of 
OSA was established on the basis of characteristic clinical features assessed at an 
interview with a sleep specialist and overnight oximetry showing an ODI ≥ 10 hour-1    
(Vazquez JC, 2000). Additional multi-channel respiratory sleep studies (Embletta 
Portable Diagnostic System, Medcare, Reykjavik, Iceland) or polysomnography (PSG) 
were performed if patients with a history strongly suggestive of OSA but with an ODI< 
10 per hour.  
    
 Inclusion criteria 
1. Symptomatic OSA offered CPAP.  
2. Objectively confirmed OSA (4% oxygen desaturation Index ≥ 10 /hour or AHI >4 per 
hour) (Vazquez JC 2000; SIGN 2003). 
Exclusion criteria 
1. Unable to give consent. 
2. Previous use of CPAP or Non-invasive ventilation (NIV). 
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Before clinic visit -Patients referred with suspected obstructive sleep apnoea (OSA) 
routinely had nocturnal oximetry test/ sleep study done before their clinic visit and 
were given information about the study.  
 First clinic visit- Patients were then assessed in clinics with their sleep study results.  
The diagnosis of OSA was established by overnight oximetry showing 4% oxygen 
desaturation Index (ODI) ≥ 10hour-1. Further diagnostic tests i.e. respiratory sleep 
studies or polysomnography (PSG) were done in patients to confirm the diagnosis of 
OSA if: 
 There was strong suspicion of OSA but 4% ODI <10 hour-1.   
 ODI ≥10 hour-1 but overnight oximetry pattern was not diagnostic. 
 Co-morbid cardio-respiratory and neurological conditions which could cause 
central apnoea or Cheyne - Stokes respiration. 
Patients with a confirmed diagnosis of OSA and offered CPAP were consented for 
participation in the study. Patients were asked to complete a set of questions to assess 
socio-economic status- derived from the self-coded version of National Statistics –
Socio-Economic Classification (NS-SEC) (Appendix 2). These questions were related to 
occupational status of an individual. It specifically took two different domains of socio-
economic class into account. The first one was their profession and the second one 
was their supervisory status. Incorporating this information into an algorithm, we 
were able to derive the socio-economic class of these individuals. This particular Socio 
economic classification is a validated and accepted classification used by social 
scientists. Although there was a detailed version of NS-SEC which classified individuals 
into 8 socio-economic classes, the self-coded version had a good correlation with the 
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detailed version (NSSEC 2000), is easier to use and can be completed by untrained 
individuals. The Self-coded version of NS-SEC divided individuals in to 5 socio-
economic classes that may be further collapsed to 3 classes. This classification did not 
include people who were long-term unemployed (unemployed for more than 6 
month) or have never worked. For our study we included these individuals as a 
separate factor. 
 Sleep related symptoms- Whether they were excessively sleepy, snored, wake 
up with unrefreshing feeling, Epworth sleepiness scale score (Appendix 1). 
 If they have a type D personality (assessed by DS-14 pro-forma) (Appendix 4). 
In this pro-forma 2 aspects of personality were assessed including social 
inhibition and negative affectivity. Individuals completed DS 14 proforma. 
Those scoring greater than 10 in either domain were considered to be having 
a type D personality.  
 Depression scores (BDI 2 - Beck’s depression inventory 2 (Appendix 5).  
 Sleep apnoea quality of life index (SAQLI - self-administered short version) 
(Appendix 6). 
 Baseline quality of life scores (Short Form- 36) (Appendix 7). 
 Nasal symptoms (Appendix 3).   
Those who agreed to accept CPAP therapy were labelled as “acceptors”. Patients who 
refused an initial trial with CPAP or failed to use CPAP at home during trial period of 6 
months were labelled as “non-acceptors”.  
 During initial assessment, before the patients were started on the CPAP treatment, 
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the physician reviewing the patient documented his/her level of confidence (indicated 
on a visual analogue scale- 0 to 100) to say the “likelihood of patients complying 
optimally (using it ≥4 hours/night) with CPAP”. Similarly, the physician also 
documented his/her level of confidence (on visual analogue scale 0- 100) to say, 
“Whether sleepiness is due to OSA” (Appendix 8). Physician's recommending the 
treatment were either sleep consultants (47 years of cumulative sleep experience) or 
research registrars (3 years of cumulative sleep experience) who saw the patients for 
the first time and recommended the CPAP treatment based on their symptoms and 
sleep study results. There were no set research or clinic parameters, to mark 
physician's assessment. These individual physicians did not get any specific pre-study 
training on how to mark these patients with OSA. Their assessment on the visual 
analogue scale was entirely based on the instinct of a clinician at the time of 
recommending the initial treatment and assessing patient's response to the 
recommendation.  
Titration with CPAP- CPAP titration was routinely performed against nocturnal 
oximetry as an in-patient. Patients were admitted to the hospital usually in the 
evening / afternoon time, when they were familiarised with CPAP, mask fitting and 
received general education about OSA and CPAP from specialist nursing / technical 
staff. Titration was performed based on a set protocol in the sleep centre. Patients 
were monitored for any drops in the oxygen saturations as well as snoring. They were 
started on a set CPAP pressure to begin with. Once asleep and still showing persistent 
snoring or drops in oxygen saturations, pressures were increased gradually to optimal 
ones to stop snoring and desaturating episodes. Following the first night of inpatient 
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titration, patients recruited in the study were asked questions related to their 
experiences following initial CPAP titration (Appendix 9). They were then seen by a 
sleep physician or specialist nurses and sent home to be followed up in the clinic. 
Those recruited in this observational study, received standard care at the sleep centre 
similar to those who were not involved in the study. 
Second clinic visit- Six to ten weeks after initiating CPAP, the patients were routinely 
reviewed in the clinic or at RSSC with another overnight oximetry on CPAP. Apart from 
routine evaluation, patients included in the study were asked to complete 
questionnaires to assess their current health status (SF-36 and SAQLI) as well as 
depression score (BDI-2). They were also asked questions related to their experiences 
on CPAP (Appendix 10). Compliance data were recorded from an internal clock in the 
CPAP, which measured the average number of hours CPAP was used per night 
(Appendix 11). Those using CPAP less than 4 hours every night was labelled “poorly 
compliant”. 
 Third clinic visit- Patients were followed up at 6 months with repeat overnight 
oximetry. Other than the routine assessment study subjects completed 
questionnaires to assess any changes in their health status (SF-36 and SAQLI) or 
depression scores (BDI-2). Questions similar to ones during their previous visit were 
asked to assess their experiences on CPAP (Appendix 12). Hours of CPAP use were 
recorded (Appendix 13).  
 If there was a clinical or CPAP related problem at any stage, which could not be dealt 
with by advice over 24-hour telephone help line, they were reviewed earlier as per 
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the standard clinical protocols at our centre.  When the patients were unable to 
attend the follow-up appointments within the expected time period for any reason, 
we posted the study questionnaires and telephoned them to get information about 
the CPAP usage and sleep symptoms.                      
              Table 5: Study visits and data collection 
 
 First Visit 6-10-week 
visit 
6-month 
visit 
Sign the study consent form X   
Medical history  X   
Epworth Sleepiness Scale score X X X 
Overnight oximetry  X X X 
Respiratory channel sleep study (if needed) * X X X 
Spirometry X   
Pro-forma to document socio-demographic  
Factors 
X   
DS –14  X   
BDI-2 X X X 
SF-36 and SAQLI X X X 
CPAP compliance assessment, experiences 
and side effects 
 X X 
 
 
 
Flow chart demonstrating protocol organisation of  
Observational CPAP compliance 
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Data collection 
 
Referred by GP with suspected OSA 
Study information given along with overnight oximetry 
equipment 
CPAP considered    
Respiratory sleep study/ PSG 
OSA confirmed / 
CPAP considered 
Reviewed in the clinic 
with overnight oximetry 
Symptoms & 
Overnight oximetry suggestive of       
OSA                                                 
Overnight Oximetry 
pattern not 
suggestive of OSA  
Invited to participate in the 
study 
Agrees  / consented Declined  
Overnight in-patient titration Excluded from study 
Follow- up 6-10 weeks 
Follow – up at 6 months 
CPAP not considered 
(Clinical decision) 
Excluded from study 
No OSA 
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The following data were collected on case record forms (CRF) and also stored in 
Microsoft excel spreadsheets which were password protected.  
1)  Patient characteristics 
     Hospital and study ID number 
     Date of Birth 
     Date of visit 
     Sex  
     Height 
     Weight 
     BMI 
     Collar size 
     Waist circumference 
2) Medical, Sleep and socio-demographic history  
     Cardio respiratory conditions 
     Other medical problems 
     Smoking history 
     Epworth Sleepiness Scale score (ESS): Baseline and follow-up 
     Socio-economic class- National statistics socio-economic class (NS-SEC), Self- 
     coded versions: Baseline 
     Physician's prediction of "likelihood of complying optimally on CPAP on a visual   
     analogue scale". 
     Physician's prediction of "OSA as a likely cause of individual's symptoms". 
3) Psychological assessment 
   Beck’s depression Inventory-2 (BDI-2): Baseline and follow-up 
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       D scale- 14 (DS-14): Baseline 
4) Quality of life scores 
       Short form- 36 (SF-36): Baseline and follow-up 
       Sleep apnoea quality of life index score (SAQLI): Baseline and follow-up 
 5) Oximetry or Respiratory sleep study 
 6) Spirometry – 
        Forced expiratory volume in 1 second (absolute and % predicted): Baseline 
        Forced vital capacity (absolute and % predicted): Baseline 
        Forced expiratory volume percentage (FEV %) 
 7) CPAP start date, acceptance, compliance and side effects. 
    
 Statistical Analysis 
 
 The primary outcome CPAP compliance as average hours of CPAP use per night was 
measured on a continuous scale. Main risk factor of interest was socio economic 
status (SES) variable. This had 5+1 levels.    
 In order to assess the required sample size, we used the following parameters and 
made the following assumptions: 
 The calculations were based upon the F-test for ANOVA. 
 There will be equal numbers of patients in each SES group.   
 Four values for the difference in compliance time between the lowest and 
highest groups were investigated (0.5 hour, 1 hour, 1.5 hours and 2.5 hours).   
 Two values for the number of SES levels were investigated (4 and 6 levels). 
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 Mean hours of CPAP use was 3 hours per night in obstructive sleep apnoea 
patients in the SES group with the worst compliance.  This comes from an 
estimate from retrospective CPAP compliance data for mean hours CPAP use 
in non-compliant patients.   
 CPAP use will be approximately normally distributed. 
 The between-patient standard deviation in sleep apnoea patients is 1.5.  This 
number was obtained from Mortimor et al (Mortimer LL,1998) in patients with 
sleep apnoea/hypopnoea syndrome or SAHS and Ayalon et al (Aylon L, 2006) 
in patients with Alzheimer’s and OSA.  This was also the approximate standard 
deviation in the <4h and >=4h compliance groups from CPAP data provided by 
the investigators.  
 The significance level used as 0.05/2.  The usual significance level was divided 
by 2 because we have 2 related outcomes, CPAP use at 6 weeks and at 6 
months.   
 We performed sample size calculations in order to obtain 80% power to detect 
differences. 
 The SAS Proc Power procedure (SAA/ SAT 9.2) was used for all calculations. 
 
To derive the sample size, we reviewed the compliance figures taken from a cohort of 
patients who were followed up at the sleep centre. Taking information from 
compliance into account and using above assumptions and with the primary risk 
factor as the socioeconomic status (SES) variable in its 5-level form, it was postulated 
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that 240 patients would have given 80% power to detect a 1-hour difference between 
the groups with the lowest and highest CPAP compliance.  We expected that a 
proportion of patients might not accept treatment. Taking them into account we 
planned to recruit 260-280 patients in the study to measure any significant difference 
in the compliance between different socioeconomic groups.  
 
Analytical methods 
Statistical analysis was done using SPSS 22[SPSS Inc, IBM]. A non-parametric 
Kolmogorov–Smirnov test (K–S test or KS test) was used to assess the normality of 
distribution of continuous variable. Further statistical tests were applied depending 
upon the distribution of the data. Most of the variables including compliance data 
were non-normally distributed. Hours of use between different exploratory groups 
were summarised by median and interquartile range (IQR). Ordinal and categorical 
variables were correlated using non-parametric Mann-Whitney U test. Compliance 
between different groups was compared using Chi Square test. Odds ratios were 
calculated to assess the impact of different factors influencing compliance. 
Multivariate analysis could not be done due to small number of variables, which were 
found to be associated with sub-optimal compliance. 
Association between different factors affecting acceptance with CPAP was looked at 
using Chi Square tests. 
To assess the significance of the physician’s confidence to predict sub-optimal 
compliance Mann-Whitney U test was used for comparative assessment.  
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Reciever operator curve (ROC) analysis was done to look for a specific value marked 
by physician on a visual analogue scale, which may predict sub-optimal compliance.  
To assess dependence of early with late compliance on CPAP, Spearman’s rank 
correlation coefficient was used.  R-values were calculated using automated analysis 
on SPSS.  Strength of association between the 2 variables was considered strong or 
weak depending upon how high or low the r-value was (Evans JD, 1996): 
        0.0 -  0.19 – Very weak 
        0.2 -0.39 - Weak 
        0.4 -0.59 - Moderate 
        0.6 -0.79 - Strong 
        0.8 -1.0 - Very strong 
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2.3    The impact of changing the pressure generating device in people 
with sleep apnoea using CPAP less than 4 hours per night 
2.3.1   Introduction 
I carried out this study looking at the impact of change to a Bi-level PAP device in 
patients who are sub-optimally compliant with fixed pressure CPAP and have 
complained of symptoms suggestive of pressure intolerance.  The study was carried 
out at the Respiratory Support and Sleep Centre at Papworth hospital, Cambridge. 
The study subjects were recruited from a cohort of 5000 patients with OSA on CPAP 
followed up at the sleep centre. The protocol was approved by Cambridgeshire 
research and ethics committee (09/H0308/68).  
2.3.2   Study Design 
This was a two-period, two-treatment, crossover, randomized, and controlled trial. 
The treatment arms were 4 weeks long with a 2-week washout period between them.  
2.3.3   Population 
Subjects were recruited from June 2009 to November 2010 inclusive. Potential 
subjects were screened from individuals under follow up at RSSC.  
Inclusion criteria were:   
 A confirmed diagnosis of OSA (apnoea/hypopnoea index [AHI] ≥5)  
 Being prescribed CPAP for at least 6 weeks  
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 Compliance with CPAP of <4 hours per night (despite: re-titration to the 
minimal, effective pressure; review of mask fit and addition of humidification 
as appropriate) 
 Symptoms to suggest pressure intolerance.   
Exclusion criteria were:  
 Significant airflow obstruction (FEV1/FVC % < 60%)  
 Pre- treatment study showing central sleep apnoea (central events more 
than 50% of AHI) 
 Daytime hypercapnoea (PaCO2 >6.5 kPa) or  
 Previous prescription of Bi-level PAP. 
 Included in other CPAP compliance study 
 Decompensated cardiac failure on clinical examination 
 Declined consent 
 AHI less than 5 per hour 
All subjects meeting the inclusion criteria were invited to join the study and those 
consenting to participate completed a baseline assessment (vide infra) and were then 
randomized to either Treatment A or Treatment B.  Treatment A was Bi-level PAP 
(NIPPY-S, B and D Electromedical Ltd, Stratford upon Avon U.K.) and Treatment B was 
a fixed CPAP machine different from the one they had used prior to entering the study 
(Phillips/ Respironics, Remstar plus M series with CFLEX disabled). They were reviewed 
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and repeated measurements taken at 4 weeks. After 2 weeks’ washout, they were 
issued with the alternative treatment they had not yet used. The diagnosis of OSA was 
confirmed using respiratory sleep studies (Embletta Portable diagnostic system, 
Medcare, Reykjavik, Iceland) and repeated in both arms of the intervention to ensure 
that sleep apnoea was adequately controlled. Sleep studies were scored as per the 
standard American Academy of Sleep Medicine [AASM 2007]. A trained and 
accredited sleep physiologist or sleep trainee, as part of the normal clinical practice, 
reported sleep studies.    
Outcome measures 
The following measurements were recorded at baseline, 4 and 10 weeks: 
Primary 
1. Compliance- was measured as average number of hours of CPAP use per night 
measured by inbuilt clock counter in the CPAP or Bi-level PAP machine. 
 Secondary 
2. Sleepiness-  
(a) Epworth sleepiness scale (ESS) score was used to measure any changes in 
subjective sleepiness.  
(b) Objective changes in daytime sleepiness were assessed by a modified OSLER 
maintenance of wakefulness test (MWT). The original protocol for the OSLER was for 
4 tests through the day. It has been shown that a single test in the morning around 
09:00 am (at least 2 hours after waking up) is a reliable substitute for the full protocol 
(Mazza S, 2002) 
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3. Quality of life- The ‘sleep apnoea quality of life index’ (SAQLI) was used to measure 
changes in the sleep related quality of life, following intervention with Bi-level PAP or 
new CPAP. A change in SAQLI score of 1 is considered to be a significant change (Ward 
W, 2002).  
4. Comfort level and preference- The comfort level with each PAP device was 
measured at each change on a visual analogue scale with measurements from 0-100. 
Subjects were asked their treatment preference at the end of the trial.  
 
 
Study type and duration 
 
The study was a two period, two treatments randomised crossover trial design. 
Patients with average CPAP use less than 4 hours per night who met the inclusion and 
none of the exclusion criteria were randomized to either receive NIPPY-S first or to 
receive a brand of fixed CPAP machine different from the one they have used previous 
to entering the study. They also had a baseline measure of CPAP compliance, daytime 
sleepiness and quality of life.  Patients randomized to receive NIPPY-S in the first 
period received CPAP in the second period and vice versa. Both groups received a 
similar level of continuing clinical support by the CPAP practitioners and RSSC nurses 
(24-hour telephone helpline, early clinic review and advice if there is any problem) as 
per the standard clinical care at our centre.  
Titration on CPAP or Bi-level PAP was done as a day care procedure during the second 
visit, when patients were randomised to either of the PAP device. Those randomised 
to new CPAP were started on a fixed CPAP pressure; similar to the ones they were on 
before being recruited in the study. Those who were randomised to Bi-level PAP were 
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started on a IPAP similar to the previous CPAP and a fixed EPAP of 4-5. All these 
individuals have had CPAP titration as an inpatient at some stage during their 
treatment. Based on their previous inpatient assessments, they were prescribed a 
fixed pressure. Though there were minor alterations in the pressure setting based on 
their further assessment as well inability to tolerate pressures, these alterations were 
minor. For this study, we assumed that the fixed pressure they were using before 
being recruited in the study was optimal pressure.  
During the daytime titration, we used Oximetry and snoring to guide us regarding any 
changes in the pressure. These titrations were performed in the sleep unit, where 
individuals reported that they managed to sleep while the pressures were optimised.  
Once optimal titration was done, study subjects were reviewed at 4 weeks with repeat 
measurements of compliance, sleepiness and quality of life.  For the second period, 
those that received CPAP in the first period got NIPPY-S and vice versa.  They went 
home with the advice to start using the new device after 2 weeks. Till that time, they 
stayed on their initial CPAP. This gave them a washout period of two weeks. They were 
then followed up for the study at 10 weeks with repeat measures of device 
compliance, daytime sleepiness and quality of life indices to look for any measurable 
changes. 
 
Statistical analysis 
Data from a group of CPAP non-compliant patients from Papworth was used to get a 
mean and standard deviation of CPAP use in hours for use in the sample size 
calculation Sample size calculation was performed using S plus power procedure as 
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well as hand calculations. 29 patients would give 80% power to detect difference of 1 
hour between the treatments. Taking 10% drop-out into account from either arm of 
the crossover design, aim was to recruit 40 patients though with difficulty recruiting 
and low dropout rate study was stopped after recruiting 28 patients.  
Non-parametric Kolmogorov–Smirnov test (KS test) was done to determine the 
normality of distribution of continuous variable. These variables were found to be 
normally distributed. Mean hours of CPAP and Bi-level PAP were summarised at 4 
weeks and 10 weeks. The number of hours of use of CPAP (the new device) was 
compared to that on Bi-level PAP using paired t test.  The SAQLI, VAS comfort score 
and Epworth sleepiness scale scores were summarized and analysed using a paired 
samples t test as well. Side effects and patient preferences were analysed 
descriptively. 
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                    Summary flow chart of Bi-level PAP intervention study 
 
 
 
 
 
 
 
                                      
                              
 
 
           
 
 
 
 
                          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Known OSA 
CPAP use less than 4 hours/ night 
Other local problems addressed 
Overnight respiratory polygraphy off CPAP 
ABG, Spirometry 
 
 
 
 
Baseline   
o SF36  
o SAQLI  
o ESS  
o Objective sleepiness (OSLER) 
Randomise 
NIPPY-S 
NIPPY-S 
Another CPAP  
Another CPAP  
Primary – Compliance 
Secondary 
 SF36 
 SAQLI 
 ESS 
 Objective sleepiness (OSLER) 
 Side effects 
 Comfort score 
 Preference 
Consent 
4 weeks 
assessment 
10 weeks 
assessment 
Washout period of 2 weeks (Use 
original CPAP) 
First period  
Second period  
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CHAPTER 3 RESULTS 
 
3.1    Long term compliance with CPAP- single tertiary centre 
experience. 
 
CPAP was offered to 339 patients, of whom 298 (88%) accepted treatment (36 
subjects did not tolerate therapy, and 5 reported no benefit and discontinued). Fifty 
subjects were excluded from the final analysis (treatment was stopped in 19 as their 
condition improved, 24 moved to a different hospital so that their data were not 
available and another 7 were switched to Bi-level ventilation). Out of 248 who 
remained on CPAP at RSSC, 13 patients were lost to follow-up (assumed not to be 
using CPAP). Eighty-one percent (n=235) of patients continued on long-term CPAP but 
compliance data was available for 221 (195 males and 26 female).   
At baseline, median age was 50 (IQR 15.3) years, ESS score 16 (IQR 6), BMI 32.6 (IQR 
10.5) kg/m2 and ODI 20 (IQR 27)/hour. The median follow-up was 7 (IQR 1.2) years. 
Median CPAP use was 6.9 (IQR 2.2) hours / night with 87% using for ≥4 hours/ night 
(Table 6).  
There was no difference between optimum CPAP use in men and women (Table 7).  
There was no difference in CPAP use in patients with mood disorders (anxiety/ 
depression) (Table 8). There was no difference in optimal CPAP usage in patients with 
different levels of daytime sleepiness (ESS scores), (Table 9). There was no difference 
in optimal CPAP usage with increasing ODI scores, (Table 10).  
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Table 6: Baseline parameters- Long-term compliance study 
 
 
 Patients (10%) who reported a benefit in daytime sleepiness had sub-optimal 
compliance on CPAP compared to 35% who did not report any benefit (p= 0.039). 
Conversely, patients reporting a lack of improvement or worsening in daytime 
sleepiness symptoms were found to have suboptimal CPAP use (Odds ratio 1.3, p = 
0.026) (Table 11,12). 
      Table 7: Relationship between Sex and sub-optimal compliance 
               
CPAP  < 4 hours/ night ≥ 4 hours / night 
Females  4 (16.0%)  21 (84%) 
Males  25 (12.8%) 171 (87.2%) 
                                                                                                                                           p = NS                     
Sex (M/F) 196/25 
Age in years- Median (IQR) 50.27 (15.3) 
Baseline oxygen desaturation index- Median (IQR) 
hour-1 
20 (27) 
Epworth sleepiness scale- Median (IQR) 15.7 (6) 
Compliance in hours per night (IQR) 6.9 (2.1) 
BMI in Kg.m-2 32.6 (10.5) 
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       Table 8: Relationship between anxiety / depression vs. compliance 
   
Anxiety/ 
Depression 
 CPAP < 4 hours/ night                          CPAP ≥ 4 hours / night 
Present  2 (28.6%) 5 (71.4%) 
Absent  27 (12.6%) 187 (87.4%) 
                                                                                                                                      p=NS 
                       Table 9: Relationship between ESS vs. compliance 
 
ESS CPAP  < 4 Hr./ night CPAP ≥4 Hr./ night 
<11   5 (19.2%) 21 (80.8%) 
11-16 11 (13.4%) 71 (86.6%) 
>16   8 (8.2%) 89 (91.8%) 
                                                                                                                                     p=NS 
   Table 10: Relationships between Desaturation Index and compliance 
 
Desaturation Index (/ Hr.)  CPAP <4 Hr./ Night  CPAP ≥ 4 Hr./ Night  
< 10   7 (13.0%)  47 (87%) 
10- 15   5 (13.5%)  32 (86.5%) 
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15.1 -30  10(17.5%)  47 (82.5%) 
>30   7 (9.6%)  66 (90.4%) 
                                                                                                                                   p=NS 
    Table 11:  Relationships between Changes in ESS vs. Compliance 
 
Current ESS CPAP < 4 Hr./ night CPAP ≥4 Hr./night 
Less than baseline 19 (10.1%) 169 (89.9%) 
Equals to / worse than 
baseline 
  6 (35.3%) 11 (64.7%) 
                                                                                                                                 p=0.039 
          Table 12: Factors associated with long-term compliance 
 
 OR for suboptimal compliance at 
last visit (p value) 
Age >60  4.2 (0.025) 
Males vs Females 0.768 (NS) 
Most recent ESS> Baseline ESS 1.3 (0.026) 
ESS≤ 10 vs. >10 at baseline 2.02 (NS) 
DI ≤ 20 (vs. >20) at baseline 1.65 (NS) 
Anxiety/ Depression  2.77 (NS) 
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3.2    A prospective observational study to evaluate the effect of social 
and personality factors on Continuous positive airway pressure (CPAP) 
compliance in Obstructive sleep apnoea. 
Study Population 
The study recruited over a period of 7 months. Screening was performed on 1400 
patients with a suspected diagnosis of OSA. During the study period 566 patients were 
started on CPAP at the centre. Of these, 410 were initialy seen by sleep specialists at 
the Papworth sleep centre and others were admitted to start the therapy, based on 
sleep studies and assessment by specialists at the referring hospitals. Amongst the 
patients assessed at the sleep centre, 265 who were recommended CPAP therapy 
consented to participate in the study. The decision to start them on CPAP treatment 
was based on the assessment by a sleep disorders specialist. There were 205 men 
(male to female ratio 3.4:1). Expressed as median (IQR): at baseline the age of 
participants was 53 (44-61) years, ESS 15 (11-17), BMI 34.8 (31.6- 41.7) kg/m2 and ODI 
21 (12.3- 41.2) per hour.  
One hundred and twenty subjects (45%) were classified as Type D personality. At 
baseline 32% subjects were taking antidepressant medication or said that they had 
previously been diagnosed with depression by their general practitioner and 45% of 
subjects had a BDI-2 score of > 13.  
From the cohort of 265 subjects, 9 were switched to a Bi-level device, 5 were excluded 
(one was diagnosed with an upper airway malignancy, another was cured of OSA by 
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tonsillectomy, 3 did not attend any follow-up visit during the study period), and 5 
withdrew consent.  
‘Acceptance’ was calculated as proportion of individuals still using CPAP after 6 
months. Non-acceptors were defined as those who either did not take CPAP home 
after the initial trial on the night of the titration or stopped treatment after a period 
of time. Individuals who repeatedly failed to attend the follow-up appointments 
despite reminders represented a challenge. For this study we considered them as non-
acceptors, assuming they were not using the CPAP regularly, although this was 
unknown.  
Two hundred and twenty-one subjects (90%) were still using CPAP at 6 months.   
There was a strong correlation between early compliance (measured as hours of use 
at first follow-up 6-10 weeks) and 6 months’ compliance (r = 0.77) (Figure 3).  
Figure 3: Correlation between early and late compliance with CPAP 
 
 
 
 
 
 
 
 
Correlation between early (6-10 weeks) and late CPAP compliance (6 months) 
                                                                                                           r = 0.77 (p<0.05) 
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The median use at first follow up and 6 months were, 6.0 (4.2-7.5) and 5.6 (3.4- 7.1) 
hours / night respectively.  By definition 19 % were using CPAP sub-optimally at first 
visit and 27 % at 6 months. 
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                     Flow chart of compliance study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clinical recruitment – 
July 2008- Jan 2009 
566 patients started 
on CPAP in the sleep 
centre 
410 seen first in the 
clinic 
265 patients 
agreed to 
participate in the 
study 
     19 excluded  
     Nine were switched to BiPAP 
     Five withdrew consent 
     Three had no baseline or further follow up questionnares  
     One was diagnosed with upper A malignancy  
     One was cured after tonsillectomy 
221 still using CPAP at 
6 months- included in 
final analysis 
25 stopped treatment at 
variable interval (non-acceptors) 
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The distribution of different SEC categories within the study population is shown in 
Table 13. The hours of use in each SEC category at first follow up and at 6 months are 
shown in Figures 4 and 5 respectively. Compared to individuals who were working (or 
retired from work), those who were long-term unemployed had lower, median hours 
of CPAP usage at first follow up and at 6 months (Table 14). This group was also more 
likely to use CPAP sub-optimally (< 4 hours / night) at first follow up visit and at 6 
months (OR 3.3, and OR 4.59 respectively, see Table 15, 16 a and 16b).  Patients with 
high BDI-2 scores indicating underlying depression were more likely to have 
suboptimal use of CPAP.  
Table 13: Distribution of OSA patients in different socio-economic status 
groups 
 
Socio-economic status Number Percentage 
1 107 40.4 
2 8 3.0 
3 45 17.0 
4 47 17.7 
5 24 9.1 
Unemployed- not working 19 7.2 
Missing 15 5.7 
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Figure 4 Socioeconomic class vs. CPAP compliance at first visit   
  
 
Figure 5:  Socioeconomic class vs. CPAP compliance at 6 months        
 
 
   Above figures shows average compliance and its association with socioeconomic 
groups during first and 6 months followup.  
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Table 14a:  Median hours of use at first follow-up for subjects using CPAP in 
different sub groups defined by study characteristics. 
 
 First follow-up  
(6-10 weeks)  
Median hours of use (IQR) 
per night  
p value 
Long-term unemployed vs Employed 
 
4.2 (3.8-5.3) vs.  
6.3 (4.3- 7.5) 
0.028 
Education: Bachelor degree vs Lower 
educational qualification 
 
6.04 (4.14-7.49) vs.  
5.90 (4.53-7.42) 
NS 
Type D personality vs Non Type D 6.00 (4.2-7.22) vs.  
6.07 (4.22-7.49) 
NS 
Previous diagnosis of depression vs 
No depression 
6.87 (2.92-7.85) vs.    
6.00 (4.22- 7.17) 
NS 
BDI>13 vs ≤ 13 6.00 (4.14-7.65) vs.  
6.15 (4.36-7.26) 
NS 
BDI≥29 vs <29 4.72 (4.30-7.49) vs.  
6.20 (3.98-7.19) 
NS 
Anxiety vs No Anxiety 6.46(3.77-7.87) vs.  
6.00 (4.22 -7.22) 
NS 
Age (greater than 70yr vs ≤ 70 ) 7.02 (6.6- 7.23) vs.  
6.00 (4.1-7.46) 
NS 
Sex (male vs females) 6.00 (4.2-7.2) vs. 
6.36 (4.18-7.19) 
NS 
ESS>10 vs ≤10 
 
6.02 (4.14-7.45) vs.  
6.0 (4.63-7.73) 
NS 
4% desaturation index >20 vs ≤ 20 6.0 (4.1-7.5) vs. 
6.04 (4.16-7.38) 
NS 
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Table 14b:  Median hours of use at 6 month follow-up for subjects using 
CPAP in different sub groups defined by study characteristics. 
 
 
 
 6-month follow-up 
 
Median hours of use 
(IQR) per night 
p value 
Long-term unemployed vs Employed 
 
2.61 (1.0 – 5.7) vs.  
5.96 (4.0- 7.2) 
0.016 
Education: Bachelor degree vs Lower 
educational qualification 
 
5.75 (3.4-7.13) vs. 
6.02 (5.01-7.1) 
NS 
Type D personality vs Non Type D 5.5 (2.9-7.1) vs.  
6.06 (4.14-7.1) 
NS 
Previous diagnosis of depression vs No 
depression 
5.61(3.00-6.90)  vs.  
5.74 (3.99-7.10) 
NS 
BDI>13 vs ≤ 13 5.01(2.62-7.37)  vs. 
5.99 (4.68-7.00) 
NS 
BDI≥29 vs <29 4.27 (2.52-6.5)  vs. 
5.98 (4.01-7.13) 
NS 
Anxiety vs No anxiety 5.01 (2.56-6.66) vs. 
5.84(4.0-7.20) 
0.09 
Age (greater than 70yr vs ≤70 ) 6.99 (5.94-7.00) vs.  
5.61 (3.4-7.1) 
NS 
Sex (male vs females) 5.59 (3.4-7.03) vs.   
5.97   (4.75-7.6) 
NS 
ESS>10 vs ≤10 
 
5.6 (3.4-7.1) vs.  
6.1 (4.17-7.2) 
NS 
4% desaturation index >20 vs ≤ 20 6.14 (3.62-7.27) vs.   
5.39 (3.2-6.99) 
NS 
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Table 15:  Distribution of subjects using CPAP ≥, or less than 4 hours per 
night by study characteristics. 
 
 First follow-up (6-10 
weeks)  
Percentage with 
characteristic and 
compliance ≤ 4 
hours/night  
p value 6-month follow-up  
 
 
Percentage with 
characteristic and  
compliance ≤ 4 
hours/night 
p value 
Long-term unemployed 
vs Employed 
45%   vs.   19% 0.046 64%   vs.  26% 0.011 
Education: Bachelor 
degree vs Lower 
educational 
qualification 
22.2% vs. 12.9% NS 29.3% vs. 6.3% 0.09 
Type D personality vs 
Non-type D personality 
21%    vs.  19% NS 33%   vs.  22% 0.056 
Previous diagnosis of 
depression vs No 
depression 
27%   vs.  18%      0.088 34%    vs.   25% 0.10 
BDI>13 vs ≤13 24%   vs.  18% NS 34%     vs.  21% 0.03 
BDI≥29 vs  <29 29%   vs.  19% NS 50%     vs.  25% 0.028 
Anxiety vs No anxiety 30%   vs.  19%  0.052 40%    vs.   25% 0.048 
Sex (male vs females 20.5%   vs. 23.8% NS 30.2%  vs.20.5 % NS 
ESS≤10 vs >10 29%   vs.  16% NS 
 
29.3% vs. 9.2% NS 
4% desaturation index 
>20 vs ≤20 
20%    vs.  23% NS 28%   vs.  30% NS 
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Table 16a: Different factors affecting compliance at first visit 
 
 OR for suboptimal compliance at first 
visit (95% confidence interval) 
P value 
Age >70  1.04 (1.01-1.08)  NS 
Type D  1.08 (0.77-1.52)  NS 
BDI   >13 1.16 (0.8- 1.7)  NS 
BDI > 29 1.6 (0.6- 4.4)  NS 
Unemployed-not working 3.3 (1.1-10.3)  0.046 
Bachelor degrees and above  0.57 (0.21-1.53)  NS 
ESS≤ 10 0.65 (.3- 1.45)  NS 
DI ≤ 20 0.90 (0.63-1.30)  NS 
Depression  1.44 (0.93-2.22)  0.08 
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Table 16b: Factors affecting compliance at 6 months 
 
 OR for suboptimal compliance at 
 6 months (95% confidence interval) 
P value 
Age >70  1.04 (1.0-1.07) NS 
Type D  1.30 (0.93-1.72) 0.08 
BDI   >13 1.40 (1.03-1.9) 0.043 
BDI > 29 2.65 (1.12-6.3) 0.03 
Unemployed-not 
working  
4.59 (1.4-15.0) 0.011 
Bachelor degrees 
and above 
1.9 (0.63-5.9) NS 
ESS≤ 10 1.07 (0.96-1.18) NS 
4% DI<20 1.04 (0.76-1.4) NS 
Anxiety 1.67 (0.99-2.84) 0.06 
Depression 1.34 (0.91-1.99) NS 
 
Physician’s prediction 
Physicians who recommended the use of CPAP treatment were able to predict 
compliance with a high degree of accuracy. The group who used CPAP for >4 hours / 
night at first visit, were given a likelihood of good compliance of 80%, while those who 
used CPAP < 4 hours / night were given a likelihood of 72% (Table 17).  The difference 
persisted at 6 months. We looked for a specific cut off point for a physician’s initial 
impression to predict sub-optimal compliance. Though the sensitivity of predicting 
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suboptimal compliance was 83 % and specificity 91 %, when a physician marked ≤ 60% 
on a visual analogue scale, on ROC analysis area under the curve was only 0.59 (Figure 
6). 
Physician's also marked their impression on a visual analogue scale as to the likelihood 
of OSA being the cause of sleepiness (whether ESS likely to improve on CPAP). No 
significant association was found between the physician's impression and change in 
ESS (Figure 7).  However, a significant correlation was found between a physician's 
ability to predict OSA as a cause of symptoms and their ability to predict optimal 
compliance on VAS (Figure 8). 
Table 17: Physician’s impression (scored between 0 and 100% on a VAS that 
a patient would use CPAP > 4hours a night) as a predictor of CPAP 
compliance. 
 
 Impression for those 
using CPAP <4 hours, 
Mean (SD) % 
Impression for those 
using CPAP ≥4 hours, 
Mean (SD) % 
 
First review 72.4 (18.03)  80.3 (13.29) P=0.018 
6 months 74.8 (17.42) 80.5 (13.90) P=0.041 
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Figure 6:  ROC analysis of physician's assessment as a predictor of 
suboptimal compliance at 6months 
 
 
 
 
 
* In the ROC curve, we looked at the diagnostic value of a physician's assessment to 
predict optimal compliance on CPAP treatment. Area under Curve (AUC) was 0.59 
 
Figure 7: ROC analysis of physician's assessment as a predictor of 
improvement in symptoms (ESS) at 6months 
 
 
 
* In the ROC curve, we looked at the diagnostic value of a physician's assessment to 
predict an improvement in symptoms at 6 months. Area under Curve (AUC) was 0.58 
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Figure 8:  Correlation between Physician’s impression in predicting 
compliance and impression in predicting OSA as a cause of symptoms  
 
  
 
 
 Figure shows correlation between Physician’s impression in predicting compliance 
and impression in predicting OSA as a cause of symptoms (r values = 0.64) 
 
Depression scores 
At 6 months, BDI 2 score threshold of 13 was statistically significant in separating the 
subjects with optimum vs. sub-optimal compliance (Table 14). This difference in 
compliance became more marked for those with BDI score > 29 and was statistically 
significant (p=0.03).  
Depression was more common in the subjects who were unemployed. Self-reported 
anxiety on enrolment to the study also predicted lower hours of use CPAP (Table 15). 
There was a trend for individuals with type D personality to comply sub-optimally at 
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6 months, but this did not reach statistical significance. No association was found 
between hours of use either at first or 6 month follow up with demographic factors 
(such as sex and age), baseline ESS, or ODI (Table 15).  
Twenty-five patients declined treatment and were not using CPAP at 6months. 
Baseline characteristics of these patients were not different from the acceptors (Table 
18).    
Table 18:  Distribution of subject’s according to non-acceptor status by study 
characteristics 
 
 CPAP acceptors vs. non-
Acceptors 
P value 
Long-term unemployed  25% vs. 9.2%  NS 
Education: Bachelor degree 8.6% vs. 13.6%  NS 
Type D personality 6.9% vs. 9.9% NS 
Previous diagnosis of depression 8.6% vs. 11.0% NS 
BDI>13 9.7% % vs. 7.3% NS 
BDI≥29 8.4% vs. 7.9% NS 
Anxiety 
(Self report) 
11.8% vs. 9.8% NS 
ESS≥10 14% vs. 9.2% NS 
4% desaturation index >20 8.3% vs. 11.7% NS 
 
111 
 
Subjects were asked to complete a questionnaire after the first night of CPAP titration.  
In this questionnaire, they recorded their experiences of side effects, as well as 
whether they thought that they were likely to continue with the treatment and 
whether there was an improvement in their symptoms on treatment.  The side effects 
included local mask related side effects, too much pressure, claustrophobia, nasal 
stuffiness and leakage, bloating and others (Table 19). The patients’ initial thoughts 
about “likelihood of continuing treatment” and experiences after first night of 
treatment are summarised in Table 20a and 20b.   
Eleven percent of individuals (n = 10) who complained of side effects after the first 
night of titration did not accept treatment compared to 5% of those who did not 
experience or record any side effects (p = 0.003) (Table 21).  Those who accepted 
CPAP but initially recorded side effects after the first night of treatment were more 
likely to comply sub-optimally with CPAP at 6 months compared with those with no 
reported adverse effects of CPAP (Table 22, p = 0.002). No significant association was 
however found between experiencing side effects and suboptimal compliance at the 
first visit (Table 23).  
Those individuals who after the first night recorded that "they are likely to continue 
with the treatment" (Table 24) or "felt better after using CPAP on the first night” were 
more likely to accept treatment though no difference in subsequent compliance at 6-
10 weeks and 6 months was noted, when compared to the other group (Table 25). 
 
 
Table 19:  Side effects on the first night of titration 
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Side effect  Frequency  Percent 
 
Noise 
 
20 
 
8.1 
Uncomfortable with mask 51 20.7 
Claustrophobia 14 5.7 
Pressure too high  11 4.5 
Bloating   9   3.7 
 
                          Table 20 a: Experiences after the first night on CPAP 
 
Experiences after the first night on CPAP Frequency Percent 
Did not complete questionnaire 35 15.8 
Tremendously better 22 10.0 
Moderate better 56 25.3 
Slightly better 55 24.9 
No improvement 48 21.7 
Worse 5 2.3 
 
Table 20 b: Experiences after the first night on CPAP “Likelihood to continue 
treatment” 
 
Experiences after the first night on CPAP Frequency Percent 
Missing info 32 14.5 
Will not continue 1 .5 
Less likely to continue 1 .5 
Probably will continue 19 8.6 
Most likely 53 24.0 
Will definitely 115 52.0 
         Table 21:  Side effects after first night on CPAP vs. Acceptance  
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 Any problems Total 
Missing 
info 
Yes No 
 Acceptors 
 
Non-
acceptors 
 34 82 105 221 
10 10 5 25 
                                                                                            p=0.003 
 
Table 22: Side effects after the titration night vs. suboptimal compliance           
at second visit 
 
Side effect on the night of CPAP 
titration 
Yes No 
Compliance<4hrs 29 (38.2%) 18 (18.6%) 
Compliance≥ 4hrs 47 (61.8%) 79 (81.4%) 
                                                                                                           p= 0.002 
 
Table 23: Side effects after the titration night vs. suboptimal compliance at 
first visit 
 
 
 
 
 
 
 
 
 
 
 
Table 24:  Association between initial experiences on CPAP with acceptance 
to treatment 
         
Side effect on the night of CPAP 
titration 
Yes No 
Compliance<4hrs 17 (21%) 17 (18.3%) 
Compliance≥ 4hrs 54 (79%) 76 (71.7%) 
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                 How likely are you to continue with CPAP 
Total 
Missing  
Info 
Will not 
continue 
Unlikely 
to 
continue 
Less 
likely to 
continue 
Probably 
will 
continue 
Most 
likely 
Will 
definitely 
 Acceptors 32 1 0 1 19 53 115 221 
14.5% 0.5% 0.0% 0.5% 8.6% 24.0% 52.0% 100.0% 
Non-acceptors 11 0 1 0 4 3 7 25 
44% 0.0% 4% 0.0% 12% 12% 28% 100.0% 
                                                                                                                              p value <0.001 
 
 
Table 25:  Association between initial experiences on CPAP with acceptance to treatment 
 
 
How did you feel after the first night on CPAP 
Total Missing Info 
Tremendo
usly 
better 
Moderate 
better 
Slightly 
better 
No 
improvem
ent Worse 
 Acceptors  35  22 56 55 48 5 221 
 15.8% 10% 25.3% 24.9% 21.7% 2.3% 100.0% 
Non- 
acceptors 
 10 0 2 2 10 1 25 
 40% 0.0% 8% 8% 40% 4% 100.0% 
Total  
45 21 57 57 58 6 246 
                                                                                                                                           p< 0.05 
 
Unemployment was more likely to be associated with non-acceptance of CPAP (OR 
3.29) than the other SEC group members. Other Socio-demographic, psychological or 
personality factors including, age, sex, ESS, severity of OSA (measured by desaturation 
index or AHI), Depression, Anxiety and type D personality were not associated with 
non-acceptance on CPAP treatment (Table 17).  
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3.3   The impact of changing to a Bi-level pressure generating device in 
people with sleep apnoea using CPAP less than 4 hours per night 
 
In this randomised crossover trial, 31 patients who met the entry criteria and gave 
consent were recruited to the study.  One developed a stroke during the treatment 
period after initial trial with NIPPY and 2 others did not complete the study (one after 
initial new CPAP and another one did not complete either limb of the study) and hence 
were excluded. 
There were 23 males and 5 females. At baseline the mean hours of CPAP use were 
1.49 hours per night (Table 26). When changed from CPAP to Bi-level PAP compliance 
improved to 2.73 hours per night (p=0.001). Reviewing sleep specific symptoms and 
QOL score (SAQLI) there were significant improvements in SAQLI scores from 3.6 to 
4.5 and ESS from 13.2 to 11.2 (Table 27a). However, there were similar changes in the 
control group with a new CPAP brand (Table 26 b). The hours of use rose to 2.30 per 
night (p=0.06), ESS fell from 13.2 to 11.5.  No changes were seen in the OLSER 
parameters with either new device.  
The key comparison, that is in the number of hours of use with Bi-level PAP and a new 
brand of CPAP showed no significant difference (Table 27c). Patients found Bi-level 
PAP more comfortable to use compared to new CPAP on a VAS (68 vs. 60mm) but this 
trend was not statistically significant.  
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                   Summary flow chart of Bi-level PAP intervention study 
                                                               
 
 
           
 
 
 
 
 
                          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
75 patients met the inclusion criteria 
31 consented and randomised 
 
 
 
 Randomise 
12 NIPPY-S 
13 NIPPY-S 
16 Another CPAP  
18 Another CPAP  
Primary – Compliance 
Secondary 
 SF36 
 SAQLI 
 ESS 
 Objective sleepiness (OSLER) 
 Side effects 
 Comfort score 
 Preference 
4 weeks 
assessment 
10 weeks 
assessment 
Washout period of 2 weeks (Used 
original CPAP) 
First period  
Second period  
 14 chose Bi-level PAP 
 11 the new CPAP 
 1 their previous CPAP 
 2 abandoned CPAP. 
 
End of the 
study 
3 Abandoned 
the trial 
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Table 26: Baseline characteristics of Bi-level PAP study 
 
 
 
 
 
  
 Mean Std. Deviation 
 Compliance on CPAP (hrs. / night) 1.49 0.89 
BMI (Kg/ m2) 35 7 
OSLER- Sleep Latency (minutes) 27.5 14.1 
OSLER – No of errors per test 30.1 27.7 
 ESS  13.2 4.7 
Sleep study (Off CPAP) 
   Mean O2 Sats (%) 
 
92.9 
 
2.5 
    4% DI (per hour) 32 25.1 
   AHI (per hour) 35.8 24.9 
SAQLI 3.6 1.3 
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Table 27a: Differences between Old CPAP and Bi-level-PAP 
 
 Baseline (Old 
CPAP) 
Bi-level-PAP P value 
Compliance (hrs. 
per night) 
1.49 (0.89) 2.73 (1.98) 0.001 
ESS 13.04 (4.6) 11.2 (4.61) 0.015 
Sleep latency 
(minutes) 
27.5 (14.09) 29.4 (13.71) NS 
No of errors 30.07 27.11 NS 
SAQLI 3.68 (1.48) 4.5 (1.43) 0.004 
 
Table 27b: Differences between Old CPAP and new CPAP 
 
 Baseline (Old CPAP)  New CPAP P  
Compliance (hrs. per 
night) 
1.49 (0.89) 2.23 (1.56) 0.006 
ESS 13.38 (4.65) 11.8(5.45) 0.06 
Sleep latency (minutes) 27.5 (14.06) 29.13 (13.00) NS 
No of errors 30.07 32.7 NS 
SAQLI 3.6 (1.51) 4.07(1.71) NS 
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Table 27c: Differences between New CPAP and Bi-level-PAP 
 
 New CPAP Bi-level PAP P value 
Compliance (hrs. per night) 2.2 (1.56) 2.7 (1.9) 0.059 
ESS 11.5 (5.34) 11.0 (4.75) NS 
OSLER Sleep latency (minutes) 29.4 (13.77) 29.1 (13.00) NS 
No of errors 32.7 27.1 NS 
Comfort level with device (0 to 
100mm) 
60 (23.5) 69 (24.2) NS 
SAQLI 4.5 (1.42) 3.95 (1.78) NS 
 
 
Table 28: Subgroup analysis 
 
 N New CPAP Bi-level PAP P value 
Compliance 
(Hours per night) 
17 1.94 (1.48) 2.63 (2.1) 0.05 
ESS 17 11 (5.0) 10.7 (4.7) NS 
OSLER sleep latency 
(minutes) 
17 31.9 (11.45) 32.8 (11.71) NS 
Comfort level with device 
(VAS 0 to 100mm) 
16 53.4 (25.28) 71.6 (17.7) 0.02 
SAQLI 17 3.9 (1.68) 4.6 (1.38) NS 
 
A post-hoc sub-group analysis was performed on the data for patients who 
complained specifically of difficulty with exhalation when on their original CPAP 
device. Bi-level PAP was superior to new CPAP for compliance and comfort. 
 
In post hoc analysis, we looked at a group who specifically complained of difficulty  
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with exhalation. Compliance was significantly better with Bi-level PAP in this group 
(2.61 vs. 1.94 hrs., p 0.05). Bi-level PAP was also found to be more comfortable to use 
in this group (VAS 53 vs. 71, p value 0.02).  
At the end of the study, patients marked their preferences for individual 
interventions, with 15 preferring Bi-level PAP, 11 the new CPAP and 2 finding no 
difference. When final machines were issued 14 chose Bi-level PAP, 11 the new CPAP, 
1 their previous CPAP. Two subjects chose to abandon CPAP treatment. Overall there 
was no significant difference in the choice of the final PAP device at the end of the 
study, comparing Bi-level PAP with new CPAP brand. 
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CHAPTER 4   DISCUSSION 
 
Obstructive sleep apnoea is an increasingly common condition (Van Dieren S, 2010). 
It causes poor health related quality of life and daytime symptoms as well as 
cardiovascular risk which may be reduced by CPAP therapy in moderate to severe 
disease (Campos-Rodriguez F, 2005). CPAP is rapidly effective (Filtness AJ, 2012) and 
symptoms are best controlled in those who use CPAP for the highest number of hours 
(Weaver T, 2008). Optimal use of CPAP is not only associated with an improvement in 
symptoms (i.e. less sleepy, improved neurocognitive performance), but is also linked 
with a reduction in road traffic accidents, better control of blood pressure and a likely 
reduction in cardiovascular complications.  
Several studies have sought association between various factors that impact on both 
short term and long-term compliance with variable results. So far, apart from an 
association between disease severity and OSA related symptoms with compliance, no 
clear and consistent association has been found.  Many of the research has been 
conducted in sleep centres, which would have had different diagnostic criteria and 
been operating in varied healthcare systems in different countries. This may, in part, 
explain the considerable heterogeneity among the results. The lack of strong 
reproducible predictive associations between measures of disease severity and the 
level of compliance with its treatment raises the question of whether these measures 
have true biological relevance.  
No research has yet explored an association between socioeconomic status derived 
by occupational and educational status (NS-SEC) with CPAP compliance. There is no 
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published literature that has examined the physician’s competence in predicting CPAP 
compliance. In individuals who are sub-optimally compliant with CPAP, there is no 
evidence that a trial with Bi-level PAP makes a difference to their hours of usage.  
My thesis sets out to explore these questions through a series of projects. These were 
to examine the long-term compliance of patients at a single centre, to explore 
relationships between socio-demographic factors, personality (Type D) and 
depression with CPAP acceptance and compliance. I also explored the ability of a 
physician to predict CPAP compliance at the time of initial visit when decision is taken 
to start CPAP. In a prospective randomised cross-over trial, I reviewed the role of Bi-
level PAP in individuals who were sub-optimally compliant with CPAP due to pressure 
related side effects. 
 
4.1    Long term compliance on CPAP- single centre experience 
 
My retrospective study explored a single centre’s experience with long-term 
compliance with CPAP. Improvement in sleepiness (change in ESS from baseline) was 
found to be associated with optimal compliance.  
McArdle et al in a prospective observational study found a higher baseline ESS to be 
linked to a better long-term CPAP compliance (McArdle N, 1999).  Barbe et al (2001) 
in their prospective study found no measurable benefit of CPAP in asymptomatic 
individuals. A meta-analysis of three trials using sham CPAP as control, showed that 
high usage of CPAP was associated with improved sleepiness (Crawford MR, 2012). 
Sin et al also demonstrated an association between improvement in ESS and better 
compliance (Sin D, 2002). It is unclear if patients who are more compliant with CPAP 
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experience an improvement in daytime sleepiness or those who experience an 
improvement in their daytime symptoms are more likely to be compliant. None of the 
current research, including my own work is able to establish a cause and effect 
association between ‘improvement in sleepiness and compliance with CPAP’.  
Although a higher ESS score at baseline has been linked with better compliance, the 
relationship has not been consistent nor predictive. McArdle et al in their multivariate 
analysis found ESS to be linked to better long-term compliance whereas the others 
have not shown the same relationship (McArdle N, Waldhorn RE 1990; Wolkove N 
2008; Ball EM 2001; Meurice JC 1994; Kreiger j 1996; Pieters T 1996; Likar LL 1997; 
Engleman HM; Kohler M 2010; Chai-Coetzer 2013). 
There was no association between the severity of OSA (measured by 4% oxygen 
desaturation index) and compliance in my study. Mean compliance between the two 
groups (those with ODI >30/ hour and < 30/ hour) and proportion of individuals sub-
optimally compliant were not different. ODI as a categorical variable demonstrated 
no relationship with CPAP compliance.  Kreiger et al, found no association between 
the ODI and mean compliance or proportion with sub-optimal compliance (Kreiger J 
1992; Kribbs NB 1993b; Budhiraja R 2007; Kohler M 2010). Disease severity as 
measured with number of apnoeas or desaturations in sleep also had little correlation 
with daytime sleepiness symptoms in the literature. Therefore, it is perhaps not 
surprising that CPAP compliance showed a stronger relationship with daytime 
symptoms rather than physiological parameters of nocturnal apnoeas.  
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Individuals with a diagnosis of depression and anxiety were less likely to be compliant 
with CPAP treatment and almost a third were using CPAP <4h/night.  Prevalence of 
anxiety and depression was lower in our retrospective study compared to what has 
been reported in the literature. Depression is diagnosed in 12-23% of unselected 
primary care patients (Moussavi S, 2007; Spitzer RL, 1995; Harold G, 1988). The 
prevalence of depression is higher in OSA patients (21-45 %) (Aikens JE, 1999a; 
Akashiba T, 2002; Sharafkhaneh A, 2005; Sharafkhaneh A, 2005; Zung WW, 1965; 
Guilleminault C, 1977; Reynolds CF, 1984; Millman RP, 1989). In my prospective study, 
a third of patients had a diagnosis of depression.   
In my study, demographic parameters such as age, sex and BMI were not associated 
with compliance. Although there is some evidence in the literature favouring 
compliance in men, this has not been demonstrated reliably in most trials (Ye L, 2009).  
In my study, a high proportion of individuals were still using CPAP and a high 
proportion were optimally compliant, compared to what usually has been reported in 
the literature. Eighty-one % of the individuals were still using CPAP at the time of data 
collection and of them 87 % were complying optimally. It is conceivable that careful 
selection of patients prior to commencing CPAP treatment may be responsible for this 
outcome. All our patients had the diagnosis of OSA established on the basis of 
overnight oximetry supported by clinical features suggestive of symptomatic OSA. 
 
There were limitations to our study. It was a retrospective study with initial data 
collection in 2003-4 and re-analysed at a later date by a single researcher (AG).  
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The diagnosis of OSA was established on oximetry rather than a detailed respiratory 
polygraphy or polysomnography. However routine use of oximetry in conjunction 
with clinical symptoms suggestive of sleep apnoea is a standard clinical practice in 
many centres in the UK, including ours. There is evidence that oximetry has good 
diagnostic specificity to accurately diagnose OSA compared to the other diagnostic 
tests for sleep apnoea (Whitelaw WA, 2005; Nicholas W 2008) 
Another limitation is that a clock counter on the CPAP machine rather than measuring 
effective mask time or there were no data for night-to-night variation measured 
compliance. However, a prospective study, which looked at, the same question, found 
effective mask time was similar to the compliance measured by clock counter device 
measurement on CPAP (Pepin JL, 1999) 
 
4.2   Social class, education and personality on CPAP compliance 
To date there have been few studies looking at the role of socio-economic status in 
acceptance of and compliance with CPAP treatment in patients with OSA. One cross 
sectional study looking at the pattern of acceptance of CPAP in an Israeli population 
found the likelihood of CPAP purchase to be determined by income level (Simon-Tuval 
T, 2009). Only 22% of individuals with low income accepted and purchased CPAP 
compared to 51% from average and 76% from higher income groups. Almost a third 
of patients declined CPAP therapy due to cost.  
 
In my study, there was no correlation between compliance and socio-economic class 
for those in work. CPAP was provided free of charge. Patients who were long-term 
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unemployed were 3.6 times more likely to demonstrate sub-optimal compliance at 6 
months.  
The number of unemployed individuals was small (19 at the start of the study), and 
this result may not be generalizable. The distributions of patients in different socio-
economic classes were similar to the one observed in previous population studies.  
Verbracken et al found no difference in the compliance between individuals 
depending on socio-economic background assessed by educational status 
(Verbracken J 2007). Bakker et al found non-European ethnicity and low socio-
economic status to be associated with poor CPAP compliance (Bakker JP, 2012). On 
multivariate analysis, factors associated with sub-optimal compliance were primary/ 
secondary education (vs. tertiary education) and high (New Zealand) deprivation 
index. Poor socio-economic status has been linked with poor adherence to asthma 
and HIV medications (Bakker JP, 2011; Apter AJ, 1998; Kalichman HC, 1999; Matthews 
KA, 2011). It is believed that the relationship between socio-economic status and 
adherence could be due to access to the treatment. In my study done within the NHS 
and in the above study, access to treatment was not an issue. It was free at the point 
of delivery.  However, for some patients in challenging circumstances, the cost of 
travel to appointments and anxiety around electricity bills associated with CPAP could 
be barriers, but we did not specifically enquire about such issues. 
 
Another explanation for the poor compliance in the unemployed group in our study 
could be a lack of education, awareness about the illness or a greater degree of 
anxiety and depression in these individuals (Matthews KA 2011; Bakker JP 2011).  
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Because of the small numbers in the different groups, regression analysis to look at 
depression and unemployment as independent risks was not feasible. 
One of the major differences between my study and other research looking at the role 
of SES is that we used NS-SEC, which takes occupation and profession into 
consideration to derive different socioeconomic classes. This did not take income into 
consideration. Other studies, which took income into consideration, were from health 
systems, that are not free at the point of delivery, and hence annual income may be 
a determinant (Greenberg H, 2004a; Greenberg H, 2006b, Joo MJ 2007; Simon-Tuval 
T, 2009, Campbell AJ, 2012). NS-SEC was the standard accepted classification in the 
United Kingdom; at the time we designed the study. Subsequently there have been 
minor modifications to the classifications (NSSEC 2011). It is widely believed that the 
parameters used in the NS-SEC are a true reflector of socio-economic class of an 
individual rather than income alone. A similar classification is used in other countries 
(Rose D, 2006; Milne BJ, 2013).   
One of the limitations to the present study is that to derive different socio-economic 
classes we used a self-coded questionnaire rather than a detailed interview based 
method, which usually takes around 45 minutes. The concordance between the self-
coded and interview based socio economic class is 76% (NS-SEC 2001). It is accepted 
that for large clinical or population studies, the self-coded version is easier to use, and 
does not require any formal training for the interviewer (NS-SEC 2001).  
A potential limitation is that we did not record SES of the individuals at the end of the 
study, especially for the ones who were either unemployed or not in work at the 
beginning of the study. Since we wished to identify factors, which could highlight the 
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need for extra support at treatment initiation, we did not build in the repeat measure. 
For completeness, this data, in retrospect would have been useful.  
Individuals who have high negative affectivity and social inhibition are classed as Type 
D personality (Dennolet J, 2005). Negative emotions in these individuals are likely to 
be associated with self-neglect with possible implications of poor adherence to 
treatment. Williams et al (Williams L, 2011) looked at the association between type D 
personality and adherence to medications three months post myocardial infarction.  
Individuals with type D personality were less likely to comply with medications. It has 
been argued that type D personality is another measure of depression and hence most 
of the effects observed within Type D individuals are the likely result of emotional/ 
affect related symptoms. However further studies (Dennelot J, 2005) suggest that it is 
the interaction between negative affect and social inhibition which adds additional 
explanatory powers compared to negative emotions or social inhibition alone. 
A retrospective study previously described that compliance with CPAP in those with 
Type D personality was on an average 1 hour 20 minutes less. Also, only 50% of 
individuals used CPAP >4 hours per night, compared to 84% of the non-type D 
personality (Brostorm A, 2007).  Prospectively, in our study individuals with type D 
personality showed no difference in the mean compliance. It is not very clear why the 
results of the previous study were different from ours. One of the arguments is that 
the Brostorm study was retrospective and type D personality construct was measured 
retrospectively after the individuals were diagnosed with OSA and already started/ 
established on the treatment. The questions asked to derive the personality trait were 
based on their current status, which may have been influenced partially by being on 
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CPAP treatment for a period of time and either succeeding or failing to benefit from 
it.   
The prevalence of depression, when diagnosed by the GP’s, in our population of OSA 
offered CPAP was 33% which is higher than estimates for otherwise unselected 
primary care patients and hospital inpatients (Moussavi s 2007). Other investigators 
have found a similar prevalence of depression (32-48%) in OSA population (Aiken JE 
1999a). In my study, individuals with a diagnosis of depression were less likely to 
comply optimally at first review and similarly those with high BDI-2 scores were less 
likely to comply at 6 months (Table 13).  
Depression is known to be associated with poor adherence to therapy in other chronic 
medical disorders (Smith A, 2006). In patients with OSA, there is conflicting evidence 
regarding any association between underlying depression and CPAP use and this may 
be partly due to the specificity and sensitivity of the screening questionnaires used. In 
a prospective study involving 70 patients, there was no correlation between CPAP 
compliance at 1 month and underlying depression measured by the Hospital Anxiety 
and Depression scores (Lewis KE 2004).  In a prospective study, baseline depressive 
symptoms measured by BDI were not correlated with CPAP compliance (Wells RD, 
2007). In a study using the Minnesotta Multiphasic Personality Inventory to measure 
depression, individuals who were depressed had poor CPAP compliance (Edinger D, 
1994).   
Depressive symptoms have been shown to improve after CPAP treatment, 
independent of compliance (Means M, 2003).  These results suggest that some of the 
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depressive symptoms in an OSA population are likely the effect of mood component 
of OSA and partially reversible. 
To the best of our knowledge this is the first study to investigate the confidence of a 
physician in predicting compliance when they reviewed the patient for the first time. 
There was a statistically significant association between a physician’s confidence that 
the individual would use CPAP and their hours of use. The differences observed were 
not large (80.3 vs. 72.5 at 6-10 weeks and 80.4 vs. 73.9 at 6 months), however this 
favours our hypothesis that a physician can predict CPAP compliance when initiating 
the treatment.  Clinicians with a range of experience made this assessment and we 
did not separately assess for association between the accuracy of prediction and 
degree of experience in sleep medicine. It is conceivable that more experienced 
practitioners might produce better predictions. 
In a study where a slightly different model was used, it was found that physician was 
more optimistic about weight loss after their review; however, they were not very 
accurate in predicting which patients will or will not change behaviours (K Pollak, 
2011). Another prospective study reviewed the role of a Physician in predicting 
compliance with digoxin, no strong association was found between the two (Gilbert 
JR, 1980).  
 
We also explored associations between the physician’s ability to predict how likely 
the sleepiness was the result of sleep apnoea. Results were very similar to their ability 
to predict compliance. Interestingly there was a good correlation between the two (r 
value 0.65). It is likely that in part it is the initial impression about the symptom 
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correlation with sleep apnoea, which influences the prediction of CPAP compliance. 
This would add value to the earlier observation that symptomatic patients are more 
likely to be compliant with CPAP treatment.  
 We did not find any association between the physiological parameters of severity of 
OSA, Epworth sleepiness scale score and CPAP compliance. A similar lack of predictive 
association has been observed by other investigators (Lloberes P, 2004; McArdle N, 
1999; Budhiraja R, 2007; Kim JH, 2009).  
One possible weakness of the current study is that we used average CPAP compliance 
measured by the clock counter on a CPAP machine rather than more accurate 
effective compliance measurement (i.e. time spent at an effective pressure during the 
night). A prospective study of 121 consecutive patients with sleep apnoea looked at 
these two modes of measuring compliance (Pepin JL, 1999). This demonstrated that 
compliance measured by in-built counter is similar to effective CPAP compliance. 
Though most of the new CPAP machines available have in-built capacity to measure 
effective compliance; average CPAP compliance measurement using clock counter is 
still a valid and acceptable practice.  
Another weakness is that we could not include consecutive patients, which might 
have led to selection bias. This was considered at the time of designing the study. In 
our centre, patients with suspected sleep apnoea are seen in a number of sleep clinics. 
Many are referred to us from other sleep centres with an established diagnosis of 
sleep apnoea. Recruiting consecutive patients in the sleep unit was therefore not 
practical.  
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Compliance follow-up data were missing in a proportion of patients (13% at first and 
7% at 6 months). These patients were repeatedly approached as per the standard 
accepted clinical practice at and in a proportion, questionnaires were sent to them. In 
future studies, remote monitoring could allow more complete data sets. 
Quality of life (QoL) data were missing during the follow-up visits in a significant 
proportion of individuals. With large number of missing QoL data it was very difficult 
to draw any valid conclusions from it; these data have not been analysed/ presented.  
In this cohort, initial acceptance of CPAP was 89 %, which compares favourably with 
published data. Early compliance measured as hours of use was highly correlated with 
compliance in the long-term (at 6 months). Subjects who were long-term unemployed 
and those with a high score on BDI-2 were less likely to use CPAP for >4 hours per 
night. Socio-economic status, education level, ESS and ODI did not predict compliance. 
Our findings suggest that people who are long-term unemployed or depressed should 
be identified and offered more intensive support when initiating CPAP therapy to give 
them the best chance of getting on with the treatment. 
 
4.3 The impact of changing to a Bi-level pressure generating device in people with 
sleep apnoea using CPAP less than 4 hours per night 
 
My randomised, crossover study examined the effects of Bi-level PAP on patients with 
poor compliance due to pressure related intolerance. Interventions in both groups led 
to a statistically significant increase in hours of use. The Bi-level device was not more 
effective in increasing the hours of use than changing to another CPAP brand.  
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Six studies comparing CPAP and Bi-level PAP showed no benefit in compliance (Smith 
IE 2009). Most of the published studies designed to investigate the impact of different 
ways of delivering PAP have studied unselected subjects, initiating therapy for the first 
time. In such studies, compliance has been better with standard treatment than in 
historical series making any treatment or intervention effects harder to demonstrate. 
To address these issues, I designed study-recruiting patients who had been poorly 
compliant with standard CPAP despite a range of interventions such as pressure re-
titration and the addition of humidification and who reported symptoms of pressure 
intolerance.   
I found an improvement in hours of use with both new CPAP and Bi-level PAP. Mean 
changes in the compliance from baseline to new CPAP were 44 minutes and 69 
minutes when the machines were changed to a Bi-level PAP. Though there were 
improvements in compliance with each intervention, these are likely to be a placebo 
effect due to treatment changes. Bi-level PAP device or new CPAP were unlikely to be 
superior to the existing CPAP.  
When comparisons were made between two interventions, there was a non-
significant difference in the compliance between the Bi-level PAP and the new PAP (p 
value= 0.059). The difference became more marked and statistically significant in a 
sub-group of patients who had complained of difficulty with exhalation (44 minutes, 
p=0.05).   
 Studies of CPAP compliance have proposed a range of cut-offs to define adequate 
use but more than 4 hours is often quoted. (Kribbs NB, 1993b; Rauscher H, 1993; 
Meurice JC 1994). There is evidence that different measures of benefit have 
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different sensitivities to hours of use. Weaver and colleagues showed benefit in the 
ESS up to 4 hours of use, in the objective multiple sleep latency tests up to 6 hours 
of use and on the Functional Outcomes of Sleep Questionnaire up to 7.5 hours of 
use. As predicted by Weaver’s results, this was associated with a fall in ESS and an 
improved SAQLI.  In my study, there was a trend towards greater use of Bi-level PAP 
but this was not statistically significant. The extra 30 minutes of use compared to a 
new CPAP device, was not associated with any difference in the daytime sleepiness 
or SAQLI. One study of 1 years’ duration showed a greater drop out for CPAP than 
Bi-level PAP (Reeves-Hoche MK, 1995). 
In a further subgroup analysis, of patients who complained of difficulty with 
exhalation, significant differences in compliance and comfort were found between Bi-
level PAP and new CPAP group.  
There were limitations to the study. Most of the patients had their Bi-level PAP and 
new CPAP introduced during the daytime. They were titrated as a day care procedure, 
with starting inspiratory pressure similar to previous CPAP. There is some evidence 
that PAP can be introduced as a day care procedure (Rabec C, 2010) and this is a 
routine practice in some UK centres. Since both the interventions were titrated 
similarly, it is less likely to have affected the comparative results between the two 
groups. 
It is conceivable that the Bi-level device was not optimally setup. Though it seems less 
likely that it would have influenced the final comparative results; as sleep apnoea 
control was not different between the Bi-level PAP and CPAP groups. Mean AHI 
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following titration was not different between the Bi-level PAP group compared to the 
new CPAP group. 
We relied on an inbuilt clock counter in the machines to measure average hours of 
use over a period of time. The equipment used in the study did not have the 
algorithms to measure night-to-night variation. Though this measurement may be 
interesting, it is the mean hours of use that has been best examined as an indicator of 
effective compliance. Three subjects dropped out after the baseline evaluation but 
their baseline parameters including compliance / daytime sleepiness were similar to 
the rest of the subjects that completed the study protocol. 
The results of this study do not support routine intervention with Bi-level PAP in 
individuals who are poorly compliant with CPAP and complain of pressure related side 
effects. A sub-group of pressure intolerant individuals who specifically reported 
difficulty with exhalation may do better with bi-level PAP though this was a post hoc 
analysis and would be more robust if a further trial were performed powered to look 
at just these individuals.  Changing to a different brand of CPAP, with a re-emphasis 
of the positive benefits of the treatment was as effective in our cohort as a placebo 
effect including the impact of the added attention offered to the subjects during the 
trial.  
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CHAPTER 5   CONCLUSIONS 
 
In a series of studies, I have explored factors, which may influence compliance with 
CPAP in OSA.  
In the retrospective, observational study (median follow up 7 years), an improvement 
in ESS from baseline was associated with optimal compliance (≥ 4 hours per night) on 
CPAP. This suggests that patients with optimal compliance demonstrate a significant 
improvement in daytime sleepiness. None of the other factors demonstrated any 
meaningful association with long-term CPAP compliance.  
I undertook a prospective, observational study to evaluate relationships between 
socio-demographic factors or Type D personality and compliance (short term and 6 
months’ compliance). I did not find any significant association between CPAP 
compliance with age, gender, symptoms or physiological severity of OSA.  
Socio-economic status (assessed by NS-SEC 2001) in a health care model, where care 
is free at the point of delivery, was not associated with compliance. Subjects who were 
unemployed long term had sub-optimal compliance.  
Subjects with depression showed a trend towards sub-optimal compliance. No 
association was found with education and Type D personality.  
Individuals who experienced side effects after the first night of titration were more 
likely not to accept the treatment and were poor compliers on CPAP.  
In this prospective observational study, I also looked at the question of whether a 
physician can predict CPAP compliance. The clinicians were able to differentiate the 
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groups of good and less good compliers but there was no useful cut off on the VAS we 
employed that would confidently identify the likelihood of individual patients needing 
extra support. 
In a prospective randomised crossover trial, I examined the impact of changes in 
positive airway pressure device in people who were sub optimally complaint with 
CPAP with symptoms to suggest pressure intolerance. While the patients found a 
change in the device gave more comfort, no statistically significant differences in 
compliance were noted when results were reviewed for the whole group. On further 
analysis, there were favourable trends to support this practice in a sub-group 
complaining of difficulty in exhalation.  
There are novel results from this series of studies but they generate more questions. 
Further research in patients who describe difficulty exhaling against CPAP could be 
helpful in assessing the impact of changing PAP delivery device and compliance with 
treatment. Exploring a robust diagnosis of mood disorders prevalent in OSA patients 
and exploring prospectively the impact on compliance would be useful.  
The value of CPAP to individual patients and to the economy more generally depends 
on people with sleep apnoea using their treatment. CPAP acceptance in our current 
practice is good in the short and long-term. Further support for people who are long-
term unemployed and or depressed might lead to even greater uptake. Bi-level PAP 
should only be issued to people with OSA with the understanding that it may have no 
impact on compliance and given the cost implications should be discontinued if the 
patient’s compliance does not improve.  
140 
 
Future directions: 
Information availaible from the series of studies that I performed provides the 
groundwork for possible future research into the factors affecting or associated with 
optimal compliance with CPAP. More research could be done particularly related to 
the mood disorders and whether there is a cohort of patients with depression who do 
not do well on the treatment. Involvement of a psychiatrist to establish firmly the 
diagnosis of a mood disorder and then examining the impact of therapy perhaps 
pharmacological or delivered by a clinical psychologist with hopefully  an impact  on 
mood / depression. In turn measures of subsequent CPAP usage will help address if 
there is a benefit over and above that directly on mood through the facilitation of 
CPAP usage.  
With the availaible information about the impact of different demographic, socio-
economic, personality, mood and diseases severity / symptoms related factors in 
predicting compliance with CPAP, a predictor model can be constructed. By giving 
different weighting to individual factors in this predictor model, we may be able to 
test a mathematical model prospectively in an appropriate clinical setting.  
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APPENDIX 1 
EPWORTH SLEEPINESS SCALE FORM  
Instructions: Be as truthful as possible. Print the form. Read the situation in the first column; select 
your response from the second column; enter that number in the third column. Total all of the 
entries in the third column and enter the total in the last box.  
Situation  Responses  Score  
Sitting and Reading  0 = would never doze 
1 = slight chance of dozing 
2 = moderate chance of dozing  3 = 
high chance of dozing  
 
Watching Television  0 = would never doze 
1 = slight chance of dozing 
2 = moderate chance of dozing  
 
3 = high chance of dozing  
Sitting inactive in a public place, for example, a 
theatre or a meeting  
0 = would never doze 
1 = slight chance of dozing 
2 = moderate chance of dozing 3 = 
high chance of dozing  
 
 
As a passenger in a car for an hour without a 
break  
0 = would never doze 
1 = slight chance of dozing 
2 = moderate chance of dozing 3 = 
high chance of dozing  
 
 
Lying down to rest in the afternoon  0 = would never doze 
1 = slight chance of dozing 
2 = moderate chance of dozing 3 = 
high chance of dozing  
 
Sitting and talking to someone  0 = would never doze 
1 = slight chance of dozing 
2 = moderate chance of dozing 3 = 
high chance of dozing  
 
Sitting quietly after lunch when you’ve had no 
alcohol  
0 = would never doze 
1 = slight chance of dozing 
2 = moderate chance of dozing 3 = 
high chance of dozing  
 
In a car while stopped in traffic  0 = would never doze 
1 = slight chance of dozing 
2 = moderate chance of dozing 3 = 
high chance of dozing  
 
TOTAL SCORE  
  
A score of 10 or greater indicates a possible sleep disorder.  
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APPENDIX 2 
THE NS-SEC SELF-CODED METHOD 
 
1. Introduction – When to use the self-coded NS-SEC 
This section of the website gives information and instructions on how to administer 
the five-class self-completion version of NS-SEC.  NS-SEC is derived from occupation 
and employment status information, occupation being ideally coded to the most 
detailed level of the Standard Occupational Classification 2000 (SOC2000).  As there 
are 353 unit groups within SOC2000, occupational coding is time-consuming and 
costly.  Therefore there is a demand for a simpler and less expensive self-completion 
version of NS-SEC.      
 
The five-class version of self-coded NS-SEC has the following classes: 
Class Label 
1 Managerial and professional occupations 
2 Intermediate occupations 
3 Small employers and own account workers 
4 Lower supervisory and technical occupations 
5 Semi-routine and routine occupations 
 
2.  Reliability of the self-coded NS-SEC 
In comparisons of the self-coded and interviewer-coded five-class NS-SEC there was 
agreement in classifying 75% of cases.  It is apparent that the self-coded five-class NS-
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SEC is not as accurate as its interviewer-coded counterpart.  Some disagreement 
between the two classifications may arise from coder error.  Despite this, validation 
exercises show that the self-coded and interviewer-coded five-class NS-SECs display 
similar patterns and strength in their relationships with other variables (eg with 
smoking).       
3.  Questions to include in self-completion questionnaires 
The self-coded version of NS-SEC is derived from a combination of information on: 
 occupation (self-classified into eight categories), and  
 an employment status variable that captures information on employment status and 
size of organisation.   
 
The latter element of NS-SEC requires knowledge of whether an individual is: 
 an employer, self-employed or an employee; 
 size of organization, and  
 Supervisory status.   
 
The following set of questions should be included in self-completion questionnaires 
in order to derive NS-SEC.  All questions refer to the respondent’s last or current 
main job. 
Employment status / size of organisation  
The following questions refer to your current main job, or (if you are not working 
now) to your last main job.  Please tick one box only per question.   
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Question 1 – Employee or self-employed 
Do (did) you work as an employee or are (were) you se 
  Employee 
  Self-employed with employees 
  Self-employed / freelance without employees (go to question 4) 
Question 2 – Number of employees (Employees) 
For employees: indicate below how many people work (worked) for your employer at 
the place where you work (worked). 
For self-employed: indicate below how many people you employ (employed).  Go to 
question 4 when you have completed this question. 
                        1 to 24  
           25 or more  
Question 3 – Supervisory Status 
Do (did) you supervise any other employees? 
A supervisor or foreman is responsible for overseeing the work of other employees 
on a day-to-day basis 
                          Yes 
                          No 
Occupation 
The following question captures the respondent's last or current main occupation. 
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Question 4 – occupation 
Please tick one box to show which best describes the sort of work you do. 
(If you are not working now, please tick a box to show what you did in your last job). 
Modern professional occupations 
such as: teacher - nurse - physiotherapist - social worker - welfare officer 
- artist - musician - police officer (sergeant or above) - software designer 
Clerical and intermediate occupations 
such as: secretary - personal assistant - clerical worker - office clerk -  
call centre agent - nursing auxiliary - nursery nurse 
Senior managers or administrators 
(Usually responsible for planning, organising and co-ordinating work and for finance) 
such as: finance manager - chief executive 
Technical and craft occupations 
Such as: motor mechanic - fitter - inspector - plumber - printer -  
tool maker - electrician - gardener - train driver 
Semi-routine manual and service occupations 
such as: postal worker - machine operative - security guard - caretaker - 
farm worker - catering assistant - receptionist - sales assistant 
  
1 
2 
4 
3 
5 
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Routine manual and service occupations 
such as: HGV driver - van driver - cleaner - porter - packer - sewing machinist - 
messenger - labourer - waiter / waitress - bar staff 
Middle or junior managers 
Such as: office manager - retail manager - bank manager - restaurant manager - 
warehouse manager - publican 
Traditional professional occupations 
such as: accountant - solicitor - medical practitioner - scientist -  
civil / mechanical engineer 
4.  Derivation of five-class NS-SEC from self-coded occupational and employment 
status variables 
There are three steps in deriving the five-class self-coded NS-SEC from the answers 
to questions 1 to 4. 
  
6 
7 
8 
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Step 1  Create the employment status variable 
The employment status variable has the following codes: 
Employment status / size of organisation 
Code Label 
1 Employers - large organisations 
2 Employers - small organisations 
3 Self-employed, no employees 
4 Managers - large organisations 
5 Managers - small organisations 
6 Supervisors 
7 Other employees 
 
The procedure to derive the employment status variable from the answers to 
questions 1 to 3 is given in the following flow-chart. 
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Flowchart  
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Step 2 Create the self-coded occupation variable 
 
On the basis of respondents' tick-box responses to question 4 create a variable with 
the following occupational codes.   
Code Label 
1 Modern professional occupations 
2 Clerical and intermediate occupations 
3 Senior managers or administrators 
4 Technical and craft occupations 
5 Semi-routine manual and service occupations 
6 Routine manual and service occupations 
7 Middle or junior managers 
8 Traditional professional occupations 
 
 
Step 3 Derive NS-SEC 
Once the employment status variable (step 1) and occupational variable (step 2) 
have been derived they are combined and an NS-SEC five-class code is assigned for 
each possible combination.  The following matrix table assigns respondents to the 
appropriate NS-SEC five-class code. In the event of cases with missing information 
on either employment status or occupation, users may choose to impute missing 
values or treat these cases as missing data.              
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A file containing the cross-classification of employment status and occupation with 
the corresponding NS-SEC code in the form of a vector can be found here 
The resulting five-class NS-SEC classification is as follows: 
 
Class Label 
1 Managerial and professional occupations 
2 Intermediate occupations 
3 Small employers and own account workers 
4 Lower supervisory and technical occupations 
5 Semi-routine and routine occupations 
  
 
NS-SEC SELF-CODED MATRIX DERIVATION TABLE: FIVE CLASSES 
Self-coded 
Occupation 
Employment status / size of organisation 
 
1  Employers - 
large 
organisations 
2  Employers - 
small 
organisations 
3  Self employed - 
no employees 
4  Managers - 
large 
organisations 
5  Managers - 
small 
organisations 
6  Supervisors 7  Other 
employe
es 
1 Modern 
professional 
occupations 
1 1 1 1 1 1 1 
2 Clerical and 
intermediate 
occupation 
1 3 3 1 1 1 2 
3 Senior 
managers or 
administrators 
1 3 3 1 1 1 1 
4 Technical and 
craft occupations 
1 3 3 1 1 4 4 
5 Semi-routine 
manual and 
service 
occupation 
1 3 3 1 1 4 5 
6 Routine manual 
and service 
occupations 
1 3 3 1 1 4 5 
7 Middle or 
junior managers 
1 3 3 1 1 1 1 
8 Traditional 
professional 
occupation 
1 1 1 1 1 1 1 
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APPENDIX 3 
                                 
Continuous positive airway pressure (CPAP) compliance study Pro-forma - first visit                                                       
Study no.                     Date 
(To be completed by patients) 
   
    Thank you for agreeing to help us with this research. Could you kindly complete the 
booklet of questionnaires designed to assess sleep related symptoms, socio-economic 
status, education, health status, mood and certain aspects of personality. This will help 
us establish a link between different factors affecting CPAP usage. Please circle the 
appropriate answers. If there are any doubts filling it up please ask the doctor or a 
specialist nurse for advice.   
 
Age -                                                        Sex -        male / female 
 
Ethnicity-                        White / Black / South Asian / Oriental / Other 
 
Marital status-               Married / Lives alone / Single but lives with partner /  Married 
but living alone / Single but living with others 
 
 
Attended clinic -             Alone / with partner  
 
What prompted referral to sleep centre-    Self / Partner / GP / Hospital consultant / 
Others  
 
If referred by a specialist then which speciality-  
                            Chest  /  Cardiology /  Endocrinology (Diabetes)  /  Neurology  /  ENT  /  
Other / not applicable 
                                                                                          
Education –  
1. No qualification 
2. School certificate only (e.g. GCSE, O level) 
3. Higher level school certification (e.g. sixth form certificate, A level), or post-school 
qualification (e.g. trade certificate diploma e.g. HNC) 
4. Bachelor’s degree or higher 
 
The following questions (a-e) aim to assess socio-economic status by 
taking into account employment and occupation. Please refer to your last 
main job and occupation. If you are a housewife- househusband then 
refer to the occupation and employment status of the main earning 
member. If you are retired please refer to your last main job before 
retirement. If you are not working for more than 6 months please skip Q a 
–d and answer Q e. 
a. Employee or self-employed - Do (did) you work as an employee or are (were) you 
self-employed?  
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1. Employee – 
2. Self-employed with employees - 
3. Self-employed / freelance without employees – 
4. Not applicable / unemployed 
b. Number of employees -    
      For employees: indicate below how many people work (worked) for your 
employer at the place where you work (worked). 
       For self-employed: indicate below how many people do (did) you employ.  
1. 1 to 24 - 
2. 25 or more – 
3. Not applicable 
c. Supervisory Status     Do (did) you supervise any other employees? 
(A supervisor or foreman is responsible for overseeing the work of other employees on 
a day-to-day basis).                                                                            Yes / No  
d. Occupation- Please tick one box which describes the sort of work you do 
    Modern professional occupations 
    Such as: teacher - nurse - physiotherapist - social worker - welfare officer    
    - artist - musician - police officer (sergeant or above) - software designer 
    Clerical and intermediate occupations 
    Such as: secretary - personal assistant - clerical worker - office clerk - Call   
    centre agent - nursing auxiliary - nursery nurse 
     Senior managers or administrators 
     (Usually responsible for planning, organising and co-ordinating work and for        
      finance)   Such as: finance manager - chief executive 
    Technical and craft occupations 
      Such as: motor mechanic - fitter - inspector - plumber - printer -  
      Tool maker - electrician - gardener - train driver 
    Semi-routine manual and service occupations 
     Such as: postal worker - machine operative - security guard - caretaker -     
     farm worker - catering assistant - receptionist - sales assistant 
    Routine manual and service occupations     
                Such as: HGV driver - van driver - cleaner - porter - packer - sewing    
 
1 
2 
4 
3 
5 
6 
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               machinist - messenger - Labourer - waiter / waitress - bar staff 
    Middle or junior managers 
     Such as: office manager - retail manager - bank manager - restaurant    
     manager - warehouse manager - publican 
    Traditional professional occupations 
     Such as: accountant - solicitor - medical practitioner - scientist - Civil /   
     mechanical engineer 
 
e. Never worked / long term unemployed-      Yes / No / Not applicable 
                    (not working for more than 6 months) 
 
    House-wife / House-husband   -                     Yes / No 
              
    Student -                                                              Yes / No 
    Retired -                                                               Yes / No 
Current symptoms                                                              Of these symptoms                                  
(Please circle yes or no)                                                     please rank the most  
                                                                                             important 1-3 (1 = most  
                                                                                                 important) 
1. Excessive daytime sleepiness                 yes / no             
         
2. Physical fatigue                                         yes / no 
                       
3. Snoring                                                       yes / no                   
 
4. Witnessed apnoeas                                  yes / no 
       (Stop breathing during sleep)      
5. Doesn’t wake up refreshed                     yes / no                   
 
6. Low mood                                                   yes / no               
 
7. Choking                                                       yes / no   
 
8. Insomnia                                                     yes / no  
      (Difficulty initiating or maintaining sleep) 
9. Poor quality sleep for the partner          yes / no  
  
10. Nocturia                                                       yes / no   
      (Wake up to pass urine during night)            
11. Any other symptom                         
 
7 
8 
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Duration of most important symptom                       ____ months____years 
 
Currently on treatment for depression                            Yes / no 
                               
Do you think you suffer from claustrophobia                 Yes / No 
                
Previous nasal surgery                                                          Yes / No 
 
Upper airway symptoms (Please mark on a scale of 0-10 how troublesome following 
symptoms are) 
 
                                            None                                                           Severe 
 
        Dry nose                             0-------------------------------------------------- 10 
 
        Runny nose                        0---------------------------------------------------10 
 
        Nasal congestion              0---------------------------------------------------10 
 
        Dry throat-                         0---------------------------------------------------10 
 
        Nasal bleeding                   0---------------------------------------------------10 
 
        Dripping feeling at the     0---------------------------------------------------10 
        Back of the throat 
 
        Reduced sense of smell   0---------------------------------------------------10 
 
     If female – Pre-menopausal/ Peri-menopausal / Post-menopausal 
 
                   If postmenopausal whether on HRT-               Yes  
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APPENDIX 4 
 
DS-14 Personality assessment Pro-forma              Study no. -              Date: 
 
Below are a number of   statements that people often use to describe themselves. 
Please read each statement and then circle the appropriate number next to the 
statement to indicate your answer. Your own impression is the only thing that matters. 
  
0 = False     1= Rather false        2= Neutral       3= Rather true      4= True 
  
1. I make contact easily when I meet people          0   1   2    3    4          8. I find it hard to start conversation    0   1   2    3    4 
 
                                                                                                                                                                                                  
2. I often make a fuss about unimportant things     0   1   2    3    4         9. I am often in bad mood                     0   1   2    3    4 
 
  
3. I often talk to strangers                                        0   1   2    3    4           10. I am closed kind of person                 0   1   2    3    4 
 
 
4. I often feel unhappy                                             0   1   2    3    4            11. I would rather keep other people     0   1   2    3    4 
                                                                                                                                  at a distance 
 
5. I am often irritated                                               0   1   2    3    4            12. I often find myself worrying               0   1   2    3    4 
                                                                                                                                  about something 
 
6. I often feel inhibited in social interactions       0   1   2    3    4            13. I am often down in the dumps          0   1   2    3    4 
 
 
7. I take a gloomy view of things                             0   1   2    3    4           14. When socializing, I don’t find the      0   1   2    3    4 
                                                                                                                                  right things to talk about 
 
 
 
˝Negative affectivity˝ scale: Add scores for questions 2, 4, 5, 7, 9, 12, and 13 
˝Social inhibition˝ scale: Add scores for questions 1*, 3*, 6, 8, 10, 11, and 14 
A person is qualified as a type D personality if they score 10 or higher on both negative affectivity and 
social inhibition scales. 
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APPENDIX 5 
 
Beck’s Depression Inventory 2 (BDI-2)               Study no. -                 Date:   
                
         This questionnaire consists of 21 groups of statements aiming to assess mood 
status. Please read each group of statements carefully, and then pick out the one 
statement in each group that best describes the way you have been feeling during the 
past two weeks, including today. Circle the number beside the statement you have 
picked. If several statements in the group seem to apply equally well, circle the highest 
number for that group. Be sure that you do not choose more than one statement for 
any group, including item 16 (changes in sleeping pattern) or item 18(changes in 
appetite). 
 
1.  Sadness 
      0     I do not feel sad 
      1.    I feel sad all the time 
      2.    I am sad all the time 
      3.    I am so sad or unhappy that I can’t stand it 
 
2. Pessimism 
1. I am not discouraged about my future 
2. I feel more discouraged about my future than I used to be 
3. I do not expect things to work out for me 
4. I feel my future is hopeless and will get only worse 
 
3. Past failure 
1. I do not feel like a failure 
2. I have failed more than I should have 
3. As I look back I see a lot of failures 
4. I feel I am total failure as a person 
 
4. Loss of pleasure 
1. I get as much pleasure as I ever did from the things I enjoy 
2. I don’t enjoy things as I used to be 
3. I get very little pleasure from the things I used to enjoy 
4. I can’t get any pleasure from the things I used to enjoy 
 
5. Guilty feelings 
         1.    I don’t feel particularly guilty 
                  2.    I feel guilty over many things I have done or should have done 
                  3.    I feel guilty most of the time 
                  4.    I feel guilty all the time 
 
6. Punishment feelings 
1. I don’t feel I am being punished 
2. I feel I may be punished 
3. I expect to be punished 
4. I feel I am being punished 
 
7. Self dislike 
1. I feel the same about myself as ever 
2. I have lost confidence in myself 
3. I am disappointed in myself 
        4.     I dislike myself 
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8. Self- Criticalness 
1. I don’t criticize or blame myself more than usual 
2. I am more critical of myself than I used to be 
3. I criticize myself for all my faults 
4. I blame myself for everything bad that happens 
 
9. Suicide thoughts or wishes 
1. I don’t have any thoughts of killing myself 
2. I have thought of killing myself but will not carry them out 
3. I would like to kill myself 
4. I would kill myself if I have the chance 
 
10. Crying 
    0      I don’t cry anymore than I used to 
    1      I cry more than I used to 
    2      I cry over every little thing 
    3      I feel like crying but I can’t 
 
11. Agitation 
      0      I am no more restless or wound up than usual 
      1.      I feel more restless or wound up than usual 
      2      I am so restless or agitated that it is so hard to stay still 
      3      I am so restless or agitated that I have to keep moving or doing something. 
 
12. Loss of interest 
1. I have not lost interest in other people or activities 
2. I am less interested in other people or activities 
3. I have lost most of my interest in other people or things 
4. It’s hard to get interested in anything 
 
13.  Indecisiveness 
1. I make decisions about as well as ever 
2. I find it more difficult to make decisions than usual 
3. I have much greater difficulty in making decisions that I used to 
4. I have trouble making my decisions 
 
14. Worthlessness 
1. I do not feel I am worthless 
2. I don’t consider myself as worthwhile 
3. I feel more worthless as compared to other people 
4. I feel utterly worthless 
 
15. Loss of energy 
1. I have as much energy as ever 
2. I have less energy than I used to have 
3. I don’t have enough energy to do very much 
4. I don’t have enough energy to do anything. 
 
16. Changes in sleeping pattern 
         0        I haven’t experienced any changes in my sleeping pattern 
         1a      I sleep somewhat more than usual 1b I sleep somewhat less than usual 
         2a      I sleep a lot more than usual            2b  I sleep a lot less than usual 
         3a      I sleep most of the day                      3b  I wake up 1-2 hour early and can’t go back to the sleep 
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17.  Irritability 
      0       I am no more irritable than usual 
      1       I am more irritable than usual 
      2       I am much more irritable than usual 
      3       I am irritable all the time 
 
18.  Changes in appetite 
       0       I  have not experienced any changes in my appetite 
      1a     My appetite is somewhat less than usual       1b    My appetite is somewhat more than usual 
      2a     My appetite is much less than usual                2b    My appetite is much greater than before 
      3a     I have no appetite at all                                      3b    I crave food all the time 
       
19.  Concentration difficulty 
       0      I can concentrate as well as ever 
       1      I can’t concentrate as well as usual 
       2      It’s hard to keep my mind on anything for long 
       3      I find it hard to concentrate on anything 
 
20.  Tiredness or fatigue 
       0      I am no more tired or fatigued than usual 
       1      I get more tired or fatigued more easily than usual 
       2      I am too tired or fatigued to do a lot of things I used to do 
       3      I am too tired or fatigued to do most of the things I used to 
 
21.  Loss of interest in sex 
        0     I have not noticed any recent change in my interest in sex 
        1     I am less interested in sex than I used to be 
        2      I am much less interested in sex now 
        3      I have lost interest in sex completely 
 
 
  
Higher total scores indicate more severe depressive symptoms. The standardized cutoffs used are: 
  0–13: minimal depression 
 14–19: mild depression 
 20–28: moderate depression 
     29–63: severe depression. 
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APPENDIX 6 
 
SAQLI (Sleep apnoea quality of life Index) -         Study no. -                Date: 
This questionnaire assesses the health status related to sleep apnoea and is designed to find out how you have been doing and 
feeling in the last 4 weeks. Please answer each question and mark it 1-7 according to the following: 
A very large = 1             A large = 2       A moderate to large = 3 A moderate = 4 
A small to moderate = 5       A small = 6  No or none = 7 
OVER THE PAST 4 WEEKS:        
    
1.   How much (amount) have you had to push yourself to remain alert during a typical day (e.g. work, school, childcare, 
housework)?              
                                                                  1            2              3            4           5           6              7 
 
2.   How have (amount of time) you had to use all your energy to accomplish your must important activity (e.g. work, school, 
childcare, housework)? 
                                                                  1            2              3            4           5           6              7 
 
3.   How much difficulty (amount) have you had finding the energy to do other activities (e.g. exercise, relaxing)?   
                                                                  1            2              3            4           5           6              7 
 
4.   How much difficulty (amount) have you had fighting to stay awake? 
                                                                    1            2              3            4           5           6              7 
 
5.   How much of a problem has it been to be told that your snoring is irritating?    
                                                  1            2              3            4           5           6              7 
 
6.   How much of a problem have frequent conflicts or arguments been?                                                                    
                                                  1            2              3            4           5           6              7 
  
7.   How often (amount of time) have you looked for excuses for being tired?                         
                                                   1            2              3            4           5           6              7 
 
8.   How often (amount of time) have you not wanted to do things with your family and/or friends? 
                                 1            2              3            4           5           6              7 
 
9.   How often (amount of time) have you felt depressed, down, or hopeless?                                                          
                                                                       1            2              3            4           5           6              7 
 
10. How often (amount of time) have you been impatient?      
                                                    1            2              3            4           5           6              7 
 
11. How much of a problem has it been to cope with everyday issues?     
                                                    1            2              3            4           5           6              7 
 
12. How much of a problem have you had with decreased energy?                                                            
                                                                       1            2              3            4           5           6              7 
 
13. How much of a problem have you had with fatigue? 
                                                                       1            2              3            4           5           6              7 
 
14. How much of a problem have you had waking up feeling unrefreshed? 
                                                                       1            2              3            4           5           6              7 
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APPENDIX 7 
 
SF- 36 (Short form 36)                   Study no. -                                  Date: 
 
  The following questions ask for your views about your health and how you feel 
about life in general. If you are unsure about how to answer any question, try and 
think about your overall health and give the best answer you can. Do not spend too 
much time answering, as your immediate response is likely to be the most accurate.   
 
1. In general, would you say your health is: 
 Excellent Very good Good Fair Poor 
       
2. Compared to one year ago, how would you rate your health in 
general now? 
 
Much better 
now than one 
year ago 
Somewhat 
better 
now than one 
year ago 
About the 
same as one 
year ago 
Somewhat 
worse 
now than one 
year ago 
Much worse 
now than one 
year ago 
       
3. The following questions are about activities you might do 
during a typical day. Does your health now limit you in these 
activities? If so, how much? 
 
Yes, 
limited 
a lot 
Yes, 
limited 
a little 
No, not 
limited 
at all 
 
 
A Vigorous activities, such as running, lifting heavy objects, 
participating in strenuous sports    
 
 
B Moderate activities, such as moving a table, pushing a 
vacuum cleaner, bowling, or playing golf    
 
 C Lifting or carrying groceries    
 
 D Climbing several flights of stairs    
 
 e Climbing one flight of stairs    
 
 f Bending, kneeling, or stooping    
 
 g Walking more than a mile    
 
 h Walking several blocks    
 
 i Walking one block    
 
 j Bathing or dressing yourself    
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4. During the past 4 weeks, have you had any of the following 
problems with your work or other regular daily activities as a 
result of your physical health? 
 Yes No 
 
 
a Cut down on the amount of time you spent on work or other 
activities   
 
 b Accomplished less than you would like   
 
 c Were limited in the kind of work or other activities   
 
 
d Had difficulty performing the work or other activities (for 
example, it took extra effort)   
 
5. During the past 4 weeks, have you had any of the following 
problems with your work or other regular daily activities as a 
result of any emotional problems (such as feeling depressed or 
anxious)? 
 Yes No 
 
 
a Cut down on the amount of time you spent on work or other 
activities   
 
 b Accomplished less than you would like   
 
 c Did work or other activities less carefully than usual   
 
6. During the past 4 weeks, to what extent has your physical 
health or emotional problems interfered with your normal 
social activities with family, friends, neighbours, or groups? 
 Not at all Slightly Moderately Quite a bit Extremely 
       
7. How much bodily pain have you had during the past 4 weeks? 
 None Very mild Mild Moderate Severe Very severe 
        
8. During the past 4 weeks, how much did pain interfere with your 
normal work (including both work outside the home and 
housework)? 
 Not at all A little bit Moderately Quite a bit Extremely 
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9. These questions are about how you feel and how things have 
been with you during the past 4 weeks. For each question, 
please give the one answer that comes closest to the way you 
have been feeling. 
 
How much of the time during the past 4 weeks... 
 
All 
of the 
time 
Most 
of the 
time 
A 
good 
bit of 
the 
time 
Some 
of the 
time 
A 
little 
of the 
time 
None 
of the 
time 
 
 a Did you feel full of pep?       
 
 
b Have you been a very nervous 
person?       
 
 
c Have you felt so down in the dumps 
that nothing could cheer you up?       
 
 d Have you felt calm and peaceful?       
 
 e Did you have a lot of energy?       
 
 f Have you felt downhearted and blue?       
 
 g Did you feel worn out?       
 
 h Have you been a happy person?       
 
 I Did you feel tired?       
 
10. During the past 4 weeks, how much of the time has your 
physical health or emotional problems interfered with your 
social activities (like visiting friends, relatives, etc.)? 
 
All of the 
time 
Most of the 
time 
Some of the 
time 
A little of the 
time 
None of the 
time 
       
11. How TRUE or FALSE is each of the following statements for you? 
 
Definitely 
true 
Mostly 
true 
Don't 
know 
Mostly 
false 
Definitely 
false 
 
 
a I seem to get sick a little easier than 
other people      
 
 b I am as healthy as anybody I know      
 
 c I expect my health to get worse      
 
 d My health is excellent      
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APPENDIX 8 
 
 
 
CPAP study Pro-forma - first visit                     Study no-                Date 
(To be completed by physician) 
 
BMI (Body Mass Index) -                           Neck size -                    cm            
 
Waist circumference -                                       cm      
 
Blood pressure -                                                 mmHg                
 
Epworth sleepiness scale -                               / 24 
 
FEV1   -                         Litres (                   % predicted) 
 
FVC    -                          Litres (                   % predicted) 
 
Overnight sleep study 
                  Mean Oxygen Saturation                  % 
                  Minimum Oxygen Saturation           % 
                  Desaturation Index                           / hour 
                  Apnoeic Hypopneic Index                / hour 
 
Co-morbidities - Hypertension / Ischemic Heart Disease (IHD) / Congestive cardiac 
failure/ previous cardiac surgery / AF / TIA / Stroke / Diabetes / Asthma/ Gout / 
Anxiety /   Depression / Hypothyroid / Other  
      
Smoking-                         Current smoker / Ex Smoker / Never smoked 
 
If current smoker or smoked in the past             ___ pack years              
 
Alcohol -                                                                       Units/ week 
                   
Compliance with other medications (Own assessment)  
1. Very good  
2. Miss it sometime 
3. Miss it frequently 
4. Not on any regular medications (pills/ Inhalers) 
 
Physician’s impression regarding OSA as a cause of sleepiness (ESS likely to improve 
on CPAP) 
                      0 _______________________⌂_____________________100                Not 
at all confident                                                                            Very confident 
 
Physician’s confidence regarding patients likely to use CPAP more than 4 hour/ night 
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                      0 _______________________⌂_____________________100 
              Least likely                                       50                                  most likely 
              to comply                                                                              to comply 
 
 
Patient’s perception 
 How much sleep did they take when well                                             hrs/ night 
               (Before sleep apnoea symptoms developed) 
 How much do they sleep now                                                               hrs/ night 
 How much sleep do the patients think they need to feel refreshed       hrs/night 
                                                                              
CPAP accepted                                                                                                 Yes / no 
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APPENDIX 9 
 
 
CPAP study Pro-forma – following titration          Study no                Date   
(To be completed by patient) 
Could you please fill-in this pro-forma, which has a number of questions to assess any 
side effects you may have experienced during first night on CPAP and your own 
assessment regarding long term usage of CPAP. 
 
1.  Did you experience any problems on CPAP            Yes* / No 
  
*If the answer to above question is “yes” then which side effect(s) did you have on the 
first night 
1. The air pressure was too high                                          
2. Uncomfortable feeling/ pain with the mask 
3. Claustrophobia 
4. Noise 
5. Nasal stuffiness / leaky nose 
6. Bloating / swallowing too much air 
7. Any other –  
 
2.  Do you feel any better following the first night of CPAP? 
 
        Tremendously / moderately / slightly / no improvement / Worse        
         better                better            better 
 
3.  In your own assessment how likely is it that you will continue with CPAP long 
term? 
 
Will not    / Unlikely /    less likely /    probably /        most likely /   will definitely 
Continue     to continue   to continue    will continue      to continue      continue 
 
 
4. How strongly do you agree with this statement? 
“I will definitely continue to use CPAP in the long term” 
 
Absolutely agree      /    Mostly agree      / neither agree nor disagree    /     
 
Mostly disagree    /    definitely disagree   
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APPENDIX 10 
 
CPAP study Pro-forma - 2nd visit                         Study no                  Date 
(To be completed by patient) 
   
 Could you kindly complete this booklet of questions which aims to assess the impact 
of CPAP treatment and any changes in health status or mood scores. This will help us 
establish a link between different factors affecting CPAP usage. Please circle the 
appropriate answers. If there are any doubts completing it please ask the doctor or a 
specialist nurse.   
 
Still using CPAP                                                                        Yes / No 
 
Any problems/ side effects on CPAP. Please mark them from 1-7,  
  (1. Very big problem, 2. Big problem,   3.Moderate to big problem,   4. Moderate 
problem,    5. Small to moderate problem,     6. Small problem,   7. No problem) 
                                     or 
Cite the reason(s) for stopping CPAP if you are not using it anymore  
 
Problems with CPAP or mask If you are still using CPAP 
then please mark  the 
problems associated with 
its use according to 
severity (from 1-7)  
If you have stopped using CPAP 
then mark the reason for 
stopping it (you can mark more 
than 1 reason in the order of 
importance).  
Pain from mask / head gear    
Unsightly mask / cosmetic reasons    
Cold air from expiratory valve   
Mask leaks                      
Claustrophobic with mask    
Too much air pressure    
Erosion / ulcer on nose   
Noise from CPAP disturbing sleep      
Local nasal side effects   
Partner doesn’t like it   
Lack of improvement in symptoms   
Any other reason -    
 
 
How much impact has the treatment had on your life    
 Tremendous       / Moderate         / Slight improvement /  No improvement  / Worse        
 Improvement       improvement 
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Upper airway symptoms -Please mark on a scale of 0-10, how troublesome following 
symptoms are  
 
                                          None                                                                   Severe 
                                                  
        Dry nose                           0---------------------------------------------------10 
 
        Runny nose                      0---------------------------------------------------10 
 
        Nasal congestion-            0---------------------------------------------------10 
 
        Dry throat-                        0---------------------------------------------------10 
 
        Nasal bleeding-                 0---------------------------------------------------10 
 
        Dripping feeling at the     0---------------------------------------------------10 
        Back of the throat 
 
        Reduced sense of smell-  0---------------------------------------------------10 
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APPENDIX 11 
 
CPAP study Pro-forma - 2nd visit                              Study no              Date   
(To be completed by physician/ CPAP practitioner) 
                                                                
BMI 
 
Date CPAP started  
          
CPAP pressure                                                              cm of Water 
 
Type of mask                                                      Nasal / Full face / Total face 
 
Any changes in mask                                         Yes / No 
 
Humidifier                                                           Yes / No  
 
Patient’s perception  
 How much do they sleep now on CPAP                             hrs/ night 
 How much CPAP do they think they are using                  hrs/ night?         
 
CPAP Hours of use-                                            Hours / Night 
 
ESS                                                                         /24 
 
ONSS results 
                  Mean Oxygen Saturation                       % 
                  Minimum Oxygen Saturation                % 
                  Desaturation Index                                / Hour 
                  Apnoeic Hypopneic Index                     / Hour 
 
Any other changes / events since previous review - 
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APPENDIX 12 
 
CPAP study Pro-forma - 3rd Visit                     Study no                     Date 
(To be completed up by patient) 
   Could you kindly complete this booklet of questions which aims to assess the impact 
of CPAP treatment and any changes in health status or mood scores. This will help us 
establish a link between different factors affecting CPAP usage. Please circle the 
appropriate answers. If there are any doubts filling it up please ask the doctor or a 
specialist nurse.   
 
Still using CPAP                                                                       Yes / No 
 
Any problems/ side effects on CPAP. Please mark them from 1-7 ;  
  (1. Very big problem, 2. Big problem,   3.Moderate to big problem,   4. Moderate 
problem,    5. Small to moderate problem,     6. Small problem,   7. No problem) 
                                     or 
Cite the reason(s) for stopping CPAP if you are not using it anymore 
        
 
Problems with CPAP or mask If you are still using CPAP 
then please mark  the 
problems associated with 
its use according to 
severity (from 1-7)  
If you have stopped using CPAP 
then mark the reason for 
stopping it (you can mark more 
than 1 reason in the order of 
importance).  
Pain from mask / head gear    
Unsightly mask / cosmetic reasons    
Cold air from expiratory valve   
Mask leaks                      
Claustrophobic with mask    
Too much air pressure    
Erosion / ulcer on nose   
Noise from CPAP disturbing sleep      
Local nasal side effects   
Partner doesn’t like it   
Lack of improvement in symptoms   
Any other reason -    
 
 
 How much impact treatment has had on your life      - 
 Tremendous       / Moderate         / Slight improvement / No improvement  / Worse        
 Improvement      improvement  
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Upper airway symptoms - Please mark on a scale of 0-10 how troublesome following 
symptoms are (0 is no problems and 10 is severe problems). 
                                          None                                                              Severe 
 
        Dry nose                           0---------------------------------------------------10 
 
        Runny nose                      0---------------------------------------------------10 
 
        Nasal congestion-            0---------------------------------------------------10 
 
        Dry throat-                        0---------------------------------------------------10 
 
        Nasal bleeding-                 0---------------------------------------------------10 
 
        Dripping feeling at the     0---------------------------------------------------10 
        Back of the throat 
 
        Reduced sense of smell-   0--------------------------------------------------10 
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APPENDIX 13  
 
CPAP study Pro-forma - 3rd Visit                                  Study no            Date   
(To be completed up by physician / CPAP practitioner) 
 
BMI 
 
CPAP pressure                                                                 cm of Water 
 
Type of mask                                                     Nasal / Full face / Total face 
 
Any changes in mask                                        Yes / No 
 
Humidifier                                                           Yes / No  
 
Patient’s perception  
 How much do they sleep now on CPAP                              hrs/ night 
 How much CPAP do they think they are using                    / night?         
 
CPAP Hours of use-                                            Hours / Night 
 
ESS                                                                         /24 
 
ONSS results 
                  Mean Oxygen Saturation                       % 
                  Minimum Oxygen Saturation                % 
                  Desaturation Index                                / Hour 
                  Apnoeic Hypopneic Index                     / Hour 
 
Any other changes / events since previous review - 
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APPENDIX 14 
 
 
CONTRIBUTION OF INDIVIDUAL RESEARCHERS IN DIFERENT STUDIES: 
 
The initial research ideas and protocol development for each of the studies arose 
from discussions and subsequent planning meetings between AG and IES. 
 
Study 1- Retrospective cohort study:  Long term compliance with CPAP- single centre 
experience-  
Initial data were collected by one researcher EM as part of another research project 
looking at possible associations between different factors predicting mortality in 
patients who are using CPAP long term. CPAP compliance related data was 
subsequently reviewed and analysed by AG. 
 
Study 2- Prospective cohort study: The impact of social and personality factors on 
CPAP compliance in OSA         
Screening, first and subsequent visit data collection was done by AG.  
Other sleep specialists at the centre, IES, MD, TQ, JMS and MA, helped with the 
recruitment and also with the first visit data collection. Subsequent review and 
analysis of data was done by AG with help from RC. 
                                                                                                          
 
Study 3- Prospective interventional study:  The impact of changing the pressure-
generating device in people who are suboptimally compliant on CPAP treatment. 
Screening, first and subsequent visit data collection was done by AG.  
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Other sleep specialists at the centre, IES, MD, TQ, JMS, NO and MA, helped with the 
recruitment and also with the first visit data collection. Subsequent review and 
analysis of data was done by AG with help from RC. 
AG = Atul Gulati 
EM = Emma Morrish 
IES = Ian Smith  
JMS= John Shneerson 
MA= Masood Ali 
MD = Michael Davis 
NO = Nick Oscroft 
RC = Rebecca Chadwick 
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